Sensory pathways of muscle phenotypic plasticity : calcium signalling through CaMKII by Eilers, Wouter
1 
 
 SENSORY PATHWAYS OF MUSCLE 
PHENOTYPIC PLASTICITY: CALCIUM 
SIGNALLING THROUGH CAMKII 
 
 
 
 
WOUTER EILERS 
 
 
 
 
A thesis submitted in partial fulfilment of the 
requirements of the Manchester Metropolitan 
University for the degree of Doctor of Philosophy 
 
 
 
Institute for Biomedical Research into Human 
Movement and Health 
the Manchester Metropolitan University 
in collaboration with MOVE Research Institute 
Amsterdam, VU University Amsterdam 
2012 
2 
 
Abstract 
Skeletal muscle can adapt its structure to cope with the mechanical and metabolic stresses 
placed on it by various amounts and patterns of human movement. The release of calcium 
into the cytoplasm of muscle fibres is thought to have an important role in these 
adaptations, yet the calcium-dependent signalling pathways involved haven’t been fully 
defined. Calcium/calmodulin-dependent protein kinase II (CaMKII) has been presumed to 
drive mitochondrial biogenesis in skeletal muscle, but this has not been investigated in 
vivo.The experiments in this thesis aimed to address how CaMKII is activated in response 
to electrical stimulation of skeletal muscle and how CaMKII affects the muscle phenotype. 
A rat model was used for two main reasons: 1) it allowed for imposing well-defined 
stimulation patterns onto phenotypically homogenous muscle fibre populations under 
controlled conditions in situ, and investigating the molecular response to these stimulation 
patterns, and 2) it allowed for manipulation of CaMKII signalling in muscle fibres in vivo 
through the use of electro-assisted somatic gene transfer.It was hypothesised that CaMKII 
would be activated in a muscle and recruitment pattern specific manner. Furthermore, it 
was hypothesised that CaMKII overexpression would increase the expression of 
mitochondrial markers. In chapter 2, the effect of recruitment frequency on CaMKII 
phosphorylation in slow-twitch m. soleus and fast-twitch m. gastrocnemius medialis is 
investigated. Furthermore, the time course of CaMKII phosphorylation after muscle 
stimulation is studied. Chapter 3 presents a study into the effects of in vivo CaMKII 
overexpression in m. soleus and m. gastrocnemius on mitochondrial gene expression and 
muscle contractile function. The effects of CaMKII overexpression on skeletal alpha-actin 
transcription are presented in chapter 4. In chapter 5, a mathematical model of CaMKII 
activation in sarcomeres is described, and used to investigate the effects of CaMKII 
overexpression on calcium handling and on contractile properties of a muscle fibre. It was 
concluded that CaMKII is activated by very brief stimulation in a recruitment frequency-
independent manner, and that increased CaMKII protein levels increase SERCA 
expression, but not mitochondrial gene expression.  
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Chapter 1: General introduction 
 
Movement of the human body occurs by activating skeletal muscles, which exert force that 
is transmitted to the skeleton via tendons and other connective tissue structures. Sufficient 
muscle mass is needed to maintain mobility throughout the human life span, but is also 
important for whole body metabolic function as muscle provides a reservoir of amino 
acids, acts as an important glucose storage site, and is important in controlling resting 
metabolic rates of the body (Wolfe, 2006). Mitochondrial abundance in muscle is 
important for fatigue resistance and is essential for the body’s capacity to use fatty acids as 
a source of energy (Hood, 2001). Maintaining good muscle health is therefore critical to 
maintaining overall health. 
Skeletal muscle is a very plastic tissue which can adapt its structure to cope with 
the mechanical and metabolic stresses placed on it by various amounts and patterns of 
human movement (Fluck and Hoppeler, 2003). Important factors that regulate adaptations 
of muscle must be present in its muscle fibres, as it has been demonstrated that while 
active muscles adapt to a training program, non-active muscles in the same body do not 
adapt or adapt to a much lesser extent (Saltin et al., 1976). Knowledge of these factors 
underlying muscle adaptation might allow for the characterisation of the intramuscular 
response to a single exercise bout, and subsequent tailoring of training protocols to the 
needs of the individual, the monitoring of training by using the regulatory molecules as 
‘progress markers’, and the development of gene and/or pharmacological therapies that 
selectively activate the signalling pathways which are important for skeletal muscle 
adaptation. This would provide the means to mimic some of the health benefits of exercise 
while eliminating the need for the actual exercise session. This could be of particular 
relevance to those who cannot exercise due to illnesses such as cardiovascular diseases and 
muscular dystrophies.  
The aim of this thesis is to investigate the role of calcium/calmodulin-dependent 
protein kinase II (CaMKII), which is hypothesised to regulate adaptation of skeletal muscle 
to exercise. This introductory chapter will discuss muscle plasticity and why it is of interest 
to investigate the role of CaMKII in skeletal muscle.      
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Skeletal muscle phenotype and function  
Skeletal muscle fibres are elongated multi-nucleated cells which consist of myofibrils 
containing highly arranged contractile protein filaments of which actin and myosin are the 
important ones. Contraction is initiated upon depolarisation of the plasma membrane of the 
muscle fibre which triggers a rise in cytoplasmic calcium concentration. This is mediated 
by the release of calcium from the sarcoplasmic reticulum (SR) through the ryanodine 
receptor (RyR). The SR is an intracellular calcium store that envelops the myofibrils. 
Calcium is continuously removed from the cytoplasm into the SR by the 
sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCA). This ensures that the intracellular 
levels of calcium are only significantly elevated when the muscle is recruited to contract. 
Cytoplasmic calcium binds to troponin C, which is part of a protein complex that blocks 
binding sites for myosin heads on the actin filaments. Upon binding of calcium to troponin 
C, the binding sites on actin are exposed and myosin heads can undergo cycles of 
attachment to actin, bending – thereby producing force – and detachment. The maximum 
force a muscle fibre can produce is determined by the number of contractile proteins 
arranged in parallel. All other things being equal, more parallel contractile filaments means 
a greater cross-sectional area of the fibre and greater maximal force. 
  As detachment of the myosin heads from the actin filaments costs energy in the 
form of ATP, it is essential that a sufficient supply of ATP to the myofilaments is 
maintained in order for muscle contraction to continue. During prolonged contraction, this 
energy is provided through anaerobic glycolysis and aerobic metabolism of carbohydrates 
and lipids. Key to this process is the generation of reduction equivalents NADH and 
FADH in the citric acid cycle, and the subsequent generation of ATP via oxidative 
phosphorylation, in the mitochondria. Mitochondrial density therefore determines the 
capacity for oxidative metabolism, and is an important factor in determining the fatigue 
resistance of skeletal muscles.  
Although there is a large heterogeneity in the skeletal muscle phenotype, a key distinction 
can be made between slow-twitch and fast-twitch fibres, which express type I and type II 
myosin heavy chain, respectively (Schiaffino and Reggiani, 2011). Fast-twitch fibres 
display higher myosin ATPase activity, which allows for a higher maximum contractile 
speed (Bottinelli et al., 1996). Human skeletal muscles are made up of a mixture of these 
two main fibre types, and a phenotypic switch from slow- to fast-twitch or vice versa is 
thought to require extreme changes in muscle activity in humans (Harridge, 2007). 
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Therefore, when studying the mechanisms underlying skeletal muscle adaptation to 
exercise, it will be important to consider the influence of fibre type on the adaptation 
process.  
 
Phenotypic adaptations of skeletal muscle 
Phenotypic adaptations in response to altered muscle recruitment allow the muscle to 
optimise its functional capacity to the demands that are being placed on it. Cross-
innervation experiments suggested that the nerve supplying the muscle affects muscle 
phenotype (Buller et al., 1960). It was later shown that specific nerve activity patterns 
could transform fast-twitch fibres into slow-twitch fibres and vice versa (Salmons and 
Vrbova, 1969) and that muscle activity, rather than substances released from the nerve 
ending, was important for changes in muscle fibre type (Lomo et al., 1974). Similarly, 
mitochondrial enzyme activity was shown to increase in skeletal muscle after training in 
rats (Holloszy, 1967) and humans (Gollnick et al., 1973), and the changes in enzyme 
activities were dependent on the nerve activity pattern (Golisch et al., 1970). These studies 
suggest the existence of local mechanisms present within skeletal muscles that connect 
recruitment-related stimuli with cellular adaptation. Experiments which demonstrate that 
isolated single fibres subjected to chronic electrical stimulation in culture display changes 
in expression of contractile proteins support that these mechanisms are, at least in part, 
present in the skeletal muscle fibres themselves (Liu and Schneider, 1998, Mu et al., 2007).   
 
The mechanisms by which muscle recruitment controls phenotypic changes in skeletal 
muscle are still unclear. Trained athletes have higher baseline levels of metabolic gene 
transcripts in skeletal muscle (Puntschart et al., 1995, Schmitt et al., 2003), which might 
underlie their superior muscle endurance. Expression of fos and jun genes, which are 
typically expressed very rapidly in response to various extra- and intracellular stimuli, is 
transiently increased after a bout of exercise (Puntschart et al., 1998), and the transcription 
of genes involved in fat/glucose metabolism is also activated within the first four hours 
after an exercise bout (Pilegaard et al., 2000, Hildebrandt et al., 2003). It has been 
demonstrated that after an exercise session changes in the expression of many genes in 
muscle occur during the first hours of recovery (Pilegaard et al., 2000, Tunstall et al., 2002, 
Pilegaard et al., 2003, Mahoney et al., 2005, Schmutz et al., 2006, Mahoney et al., 2008). 
Increased mRNA levels provide increased template for protein synthesis by translation. 
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Therefore, the cumulative effects of these changes in transcript levels might underlie 
structural changes in muscle protein expression and improved muscle function (Fluck, 
2006). 
 
It has become clear that the intracellular homeostatic disturbances that occur during muscle 
contraction are signals that activate signalling pathways which regulate gene expression 
(Fluck and Hoppeler, 2003). Figure 1 provides an overview of some of these pathway in 
skeletal muscle, and shows how CaMKII is   The increase in intracellular calcium 
concentration during muscle contraction has been linked to multiple adaptive processes, 
which will be discussed in the next section. 
 
The role of calcium in muscle adaptations 
Intracellular calcium release is directly related to the degree of activation of a muscle fibre. 
This makes calcium an excellent candidate to relay muscle use-related information to 
signalling molecules and downstream activation of pathways that coordinate changes in 
gene expression and regulate muscle remodelling. Indeed, it has been shown that changes 
in intracellular calcium concentration can induce various adaptations of skeletal muscle. 
This was first demonstrated in cultures of muscle precursor cells, where an increase in the 
intracellular cytoplasmic calcium concentration by addition of a calcium ionophore (a 
compound that facilitates the transport of calcium across the plasma membrane) resulted in 
increased expression of type I myosin heavy chain and mitochondrial enzyme citrate 
synthase, and decreased expression of type II myosin heavy chain and glycolytic enzyme 
lactate dehydrogenase (Kubis et al., 1997). Also, in whole rat muscles ex vivo, chronically 
increasing calcium levels increased transcript levels of genes encoding mitochondrial 
enzymes (Wright et al., 2007). Finally, mice exposed to cold displayed increased basal 
levels of calcium and increased citrate synthase activity in skeletal muscles (Bruton et al., 
2010). However, in all of these models the calcium concentration was chronically 
increased, which is very dissimilar to the transient increases in calcium concentration 
induced by muscle recruitment in vivo. In mice that lacked the gene for parvalbumin, an 
important calcium buffer in fast-twitch muscle, the duration of electrical stimulation-
induced calcium transients, but not basal calcium concentration, was increased, as was the 
mitochondrial density (Chen et al., 2001, Racay et al., 2006). Conversely, slow-twitch 
muscles of parvalbumin-overexpressing mice had lower mitochondrial enzyme activity 
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(Chin et al., 2003). Thus, the levels of mitochondrial enzymes can also be affected by more 
subtle perturbations of calcium levels. However, the amplitude of calcium transients in 
mice which lack calsequestrin, a calcium buffer located in the SR, in their skeletal muscles 
were reduced, and yet the fast-twitch m.extensor digitorum longus of these animals had a 
higher mitochondrial density compared to wild-type controls (Paolini et al., 2007). Note 
that conclusions drawn from studies using transgenic mice models may be influenced by 
compensatory adaptations during development. Taken together, these results suggest that 
the contraction-induced increase in calcium concentration in muscle fibres leads to an 
increase in mitochondrial biogenesis.  
 
This raises the question of how the increased calcium concentration is transduced into 
changes in gene expression. Various transcription factors that have been demonstrated to 
activate the expression of genes involved in muscle remodelling are sensitive to calcium-
dependent signalling pathways (Bassel-Duby and Olson, 2006). The two most studied 
calcium transducers in skeletal muscle are CaMKII and calcineurin, a calcium/calmodulin-
dependent protein phosphatase. Current literature suggests that calcineurin is sufficient and 
necessary to induce expression of slow fibre type-related myofibrillar proteins (Chin et al., 
1998, Naya et al., 2000, Serrano et al., 2001, Parsons et al., 2004). In addition, lifelong 
expression of constitutively active calcineurin is sufficient to increase mitochondrial gene 
expression and maximal mitochondrial respiration (Long et al., 2007, Jiang et al., 2010). 
However, inhibiting calcineurin in vivo with cyclosporin did not prevent increased 
mitochondrial gene expression in response to swimming exercise in rats (Garcia-Roves et 
al., 2006). This suggests that calcineurin is not required for increased mitochondrial 
biogenesis in response to exercise, and other pathways must be involved. 
 
CaMKII as a calcium-dependent regulator of skeletal muscle phenotype 
A possible candidate to relay calcium concentration changes to multiple adaptation 
processes is calcium/calmodulin-dependent protein kinase II (CaMKII), which is the focus 
of investigation in this thesis. CaMKII is a protein serine/threonine kinase, which has first 
been discovered in neuronal membranes (Schulman and Greengard, 1978), and is thought 
to be involved in the formation of memory (Lisman et al., 2002). Four CaMKII genes are 
present in the human genome, encoding alpha, beta, gamma and delta isoforms of CaMKII. 
All isoforms have multiple splice variants, which results in at least 38 different variants 
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being expressed in a cell-specific pattern (Tombes et al., 2003). All four CaMKII genes 
contain a N-terminal kinase domain, a C-terminal association domain and a variable 
autoregulatory region  (Hudmon and Schulman, 2002) and form dodecamers with very 
similar structures, but slightly different sensitivities for calcium-bound calmodulin 
(Gaertner et al., 2004).  
 
CaMKII is part of a larger protein family of calcium/calmodulin-dependent protein 
kinases, of which CaMKI, CaMKIV and calcium/calmodulin-dependent kinase kinase 
(CaMKK) have multiple substrates. The CaMK family of genes also includes glycogen 
phosphorylase kinase, myosin light chain kinase and eukaryotic elongation factor 2 kinase 
(also known as CaMKIII), which have single substrates.  
CaMKI seems to be expressed in mouse skeletal muscle, but not in human skeletal 
muscle (Rose et al., 2006, Witczak et al., 2007). CaMKII is expressed in rodent and human 
skeletal muscle (Woodgett et al., 1982, Rose et al., 2006). CaMKIV is expressed in neither 
human, nor rodent skeletal muscle (Akimoto et al., 2004, Rose et al., 2006). This is 
relevant, as inferences have been made about the function of CaMKII based on studies into 
the effects of other members of the CaMK family. However, CaMKII is the only 
multifunctional CaMK expressed in human skeletal muscle (Rose et al., 2006). CaMKK 
alpha, which acts upstream of CaMK’s, is also expressed in human skeletal muscle (Rose 
et al., 2006). This kinase phosphorylates CaMKI and IV, but not CaMKII (Tokumitsu et 
al., 1995), and it is therefore possible that CaMKK alpha is a part of a separate 
calcium/calmodulin-dependent pathway in skeletal muscle.  
 
The role of CaMKII in structural adaptation of skeletal muscle to exercise is currently 
unclear. CaMKII is activated during cycling exercise (Rose et al., 2006), and this 
activation depends on cycling intensity (Egan et al., 2010). However, it is not known which 
intramuscular factors related to cycling intensity are important for this regulation. Basal 
CaMKII activity was increased in rooster skeletal muscle by overloading (Fluck et al., 
2000b) and in human m. vastus lateralis by cycling exercise (Rose et al., 2007b), 
suggesting it may be involved in the adaptation to these protocols.  
CaMK's have been proposed to regulate a number of biological processes in skeletal 
muscle (Fig. 1). Transgenic mice overexpressing a constitutively active mutant of 
CaMKIV have increased mitochondrial density, which was thought to be caused by 
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increased expression of transcription co-factor peroxisome proliferator-activated receptor ɣ 
coactivator-1 (PGC-1) expression (Wu et al., 2002). Overexpression of PGC-1 increased 
mitochondrial biogenesis in cultured myotubes (Wu et al., 1999). Many studies have 
demonstrated that CaMK's can regulate the activity of various transcription factors 
involved in the regulation of PGC-1 expression, usually in cultured myoblasts (Lu et al., 
2000b, McKinsey et al., 2000a, McKinsey et al., 2000b, Wu et al., 2000, Handschin et al., 
2003). The picture emerging from these studies is that CaMK's regulate gene expression in 
skeletal muscle cells by a general mechanism involving the phosphorylation of histone 
deacetylases (HDACs; Fig. 1). HDACs bind to transcription factor, myocyte enhancer 
factor 2 (MEF2), and inhibit its transcriptional activity. Upon phosphorylation by CaMK, 
HDAC is removed from the cell nucleus and MEF2 can bind to the PGC1 promoter and 
activate PGC1 transcription. These studies suggest that CaMK activates mitochondrial 
biogenesis in skeletal muscle. However, these studies have used overexpression of 
constitutively active mutants of CaMKI or CaMKIV, neither of which is expressed in 
human skeletal muscle (Rose et al., 2006). The question remains whether CaMKII also 
regulates these factors. It has been demonstrated in cardiac myocytes that CaMKII can 
phosphorylate HDAC4, thereby inducing its export from the nucleus (Backs et al., 2006), 
and activating a MEF2-dependent reporter gene (Zhang et al., 2007), but in skeletal muscle 
this information is still missing.   
CaMKII isolated from chicken skeletal muscle phosphorylates serum response 
factor (SRF) (Fluck et al., 2000a), a transcription factor which is essential for skeletal 
alpha-actin gene transcription during skeletal muscle development (Croissant et al., 1996). 
This indicates that CaMKII may also be involved in the regulation of skeletal alpha-actin 
expression (Fig. 1), which is increased in response to stretch overloading of chicken 
skeletal muscle (Gregory et al., 1990). Furthermore, CaMKIV activates SRF-dependent 
transcriptional activity by removing HDAC4-dependent SRF inhibition in cardiomyocytes 
(Davis et al., 2003), indicating there may be another mechanism whereby CaMK’s regulate 
gene transcription in skeletal muscle through HDACs. 
 
The involvement of CaMKII in regulating gene expression in skeletal muscle and 
adaptation of its phenotype has also been suggested by studies using pharmacological 
CaMK inhibitors. Electrical  stimulation of cultured adult mouse muscle fibres results in 
export of HDAC4 from the nucleus and activation of a MEF2-dependent reporter gene, and 
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these effects are blocked by the calmodulin-competitive inhibitor KN62 (Liu et al., 2005). 
KN93, another calmodulin-competitive CaMK inhibitor, inhibits the expression of slow-
fibre type genes in cultured adult mouse muscle fibres (Mu et al., 2007). In rats, KN93 
blocked the swimming exercise-induced binding of MEF2 to the glucose transporter 4 
(GLUT4) promoter (Smith et al., 2008). These studies suggest that CaMK's are involved in 
the regulation of MEF2 activity and gene expression in whole muscle. However, inhibition 
of calcium-induced expression of mitochondrial genes by KN93 has only been 
demonstrated in cultured myotubes (Ojuka et al., 2003). Furthermore, the KN62/KN93 
inhibitors suppress the activity of all CaMK's (Wayman et al., 2008) and have effects on 
calcium/calmodulin-independent enzymes and ion channels as well (Davies et al., 2000, 
Gao et al., 2006, Ledoux et al., 1999). Therefore, it is not certain whether the observed 
effects in these studies can be ascribed to inhibition of CaMKII only.  
 
Finally, there is evidence that CaMKII has acute effects on muscle function. In mouse 
skeletal muscle, its inhibition has been shown to decrease calcium release from the SR 
(Tavi et al., 2003) and glucose uptake during muscle contraction (Witczak et al., 2010). 
 
In conclusion, although it has recently been claimed that "there is overwhelming 
experimental support for CaN and CaMKII being capable of inducing major changes in 
muscle fibre properties" (Tavi and Westerblad, 2011), the above review of the current 
literature indicates that although there are suggestions that CaMKII is a key regulator of 
the expression of genes involved in muscle fibre adaptations in vivo, this has not been 
tested yet by modifying CaMKII isoforms in vivo. 
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Figure 1: Potential intracellular signalling pathways involved in skeletal muscle adaptation to exercise 
Diagram showing how CaMKII may affect muscle phenotype by altering gene expression. In addition, 
CaMKII is thought to stimulate calcium release from, and uptake into, the sarcoplasmic reticulum. A few 
other pathways thought to be important for skeletal muscle adaptation are also shown. Note that not all 
factors currently believed to regulate muscle adaptation are included in this overview, and that the scientific 
evidence for the pathways shown here is incomplete. Recent reviews on the topic are available (Gundersen, 
2011). Abbreviations: RyR: ryanodine receptor; SERCA: sarco/endoplasmic reticulum Ca
2+
-ATPase; 
CaMKII: calcium/calmodulin-dependent protein kinase II; CaM: calmodulin; CaN: calcineurin; AMPK: 5’-
AMP-activated protein kinase; p38 MAPK: p38 Mitogen-activated protein kinase; HDAC: histone 
deacetylase; MEF: myocyte enhancer factor; CREB: cAMP-reactive element binding protein; SRF: serum 
response factor; Sk. α-actin: skeletal alpha-actin; NFAT: nuclear factor of activated t-cells; PGC-1: 
peroxisome proliferator-activated receptor gamma coactivator 1; NRF1/2: nuclear respiratory factor 1 & 
nuclear respiratory factor 2.     
 
Aims and thesis outline 
The gap in our current understanding of CaMKII function in skeletal muscle is how its 
activity is regulated in skeletal muscle by the recruitment pattern, and what the effects of 
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CaMKII are on skeletal muscle function in vivo, in slow- and fast-twitch muscle. The 
experiments in this thesis aim to address this gap in knowledge. A rat model is used, 
because it allows for imposing well-defined stimulation patterns onto phenotypically 
homogenous muscle fibre populations under controlled conditions in situ, and investigating 
the molecular response to these stimulation patterns. Furthermore, it allows for 
manipulation of CaMKII signalling in muscle fibres in vivo through the use of electro-
assisted somatic gene transfer. 
  In chapter 2, the effect of recruitment frequency on CaMKII phosphorylation in 
slow-twitch m. soleus and fast-twitch m. gastrocnemius medialis is investigated. 
Furthermore, the time course of CaMKII phosphorylation after muscle stimulation is 
studied. Chapter 3 presents a study into the effects of in vivo CaMKII overexpression in 
m. soleus and m. gastrocnemius on mitochondrial gene expression and muscle contractile 
function. The effects of CaMKII overexpression on skeletal alpha-actin transcription are 
presented in chapter 4. Experimental control is inherently limited in biological 
experiments and therefore it can be difficult to identity cause and effect. Mathematical 
modelling provides perfect control of system parameters, which allows dissecting 
biological mechanisms and generating new hypotheses. In chapter 5, a mathematical 
model of CaMKII activation in sarcomeres is described, and used to investigate the effects 
of CaMKII overexpression on calcium handling and on contractile properties of a muscle 
fibre. The thesis is concluded with a general discussion in chapter 6 of the implications of 
the results for our understanding of CaMKII function in skeletal muscle. 
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Chapter 2: Regulation of CaMKII autophosphorylation by 
recruitment and muscle type 
 
Abstract 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is activated in skeletal muscle 
during exercise, but how this activity is regulated by the pattern of muscle recruitment is 
unknown. As this likely has implications for its function, we investigated if CaMKII 
activation depends on recruitment frequency and what the time course of its activity is after 
muscle stimulation, using in situ stimulation of adult rat skeletal muscle. Protein levels of 
total CaMKII and phospho
Thr287
-CaMKII were measured for the βM, δA & δD/γB isoforms. 
In the first experiment, m. soleus (SOL) and m. gastrocnemius medialis (GM) were 
stimulated at active slack length with 100 electrical impulses at 10 or 150 Hz. This 
protocol increased phospho
Thr287
-CaMKII of δA (p=0.05) and δD/γB (p=0.05) isoforms in 
red GM (GMR), δA isoform (p=0.043) in white GM (GMW), but none of the isoforms in 
SOL. There was no effect of frequency on the level of phospho
Thr287
-CaMKII. In GMW, 
we observed a decrease in total CaMKII after 150 Hz stimulation in two isoforms (βM: 
p=0.03, δD/γB: p=0.03). In the second experiment, we sampled GM at rest, after 
determination of muscle optimum length and at 2, 10 or 60 minutes following a two-
minute isometric contraction protocol. After the contractile activity required to determine 
the optimum length, the level of phospho
Thr287
-CaMKII for the δA isoform was increased 
compared to rest in red GM (p=0.03). Levels of phospho
Thr287
-CaMKII were higher in 
GMW compared to GMR regardless of stimulation (βM: p<0.01, δA: p<0.01, δD/γB: 
p=0.01). In white GM, the level of total CaMKII decreased over time after stimulation (βM: 
p<0.01, δA: p=0.04, δD/γB: p=0.04). Our results suggest that phospho
Thr287
-CaMKII is 
increased after stimulation with 100 twitches, but that this phosphorylation is only 
detectable within 15 minutes after contraction. 
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Introduction  
Calcium/calmodulin-dependent protein kinase II (CaMKII) has been suggested to regulate 
gene expression, calcium channels and glucose transport in skeletal muscle (Tavi et al., 
2003, Wright et al., 2007, Witczak et al., 2010). The regulation of its activation likely 
determines in which context these functions are relevant. For example, if CaMKII is more 
strongly activated at high, compared to low, recruitment frequencies, it is likely to be more 
important for muscle function during high frequency muscle recruitment and muscle 
adaptation to such recruitment. CaMKII is activated by binding of calcium/calmodulin 
(Ca
2+
/CaM) (Hudmon and Schulman, 2002), and therefore, availability of Ca
2+
/CaM 
determines whether CaMKII is activated. It has been shown that CaMKII can be 
activated/phosphorylated in human skeletal muscle by exercise (Rose et al., 2006) and in 
rat fast-twitch muscle by in situ  electrical stimulation (Rose et al., 2007a). However, if and 
how this activation of CaMKII is regulated by the specific recruitment pattern is unknown.  
Following binding of Ca
2+
/CaM, CaMKII can undergo autophosphorylation at 
Thr287 and gain Ca
2+
/CaM-independent activity. In vitro, it has been shown that the 
generation of Ca
2+
/CaM-independent, or autonomous, CaMKII activity depends on the 
frequency, amplitude and duration of Ca
2+
/CaM pulses (De Koninck and Schulman, 1998). 
Motor neuron firing rate is modulated during locomotor tasks in vivo, with slow-twitch 
motor neurons firing between 5-40 Hz and fast-twitch motor neurons firing at 60-300 Hz, 
depending on the specific locomotor task  (Hennig and Lomo, 1985, Gorassini et al., 
2000). These motor unit recruitment frequencies are coupled to different frequencies of 
calcium release from the sarcoplasmic reticulum and/or differences in cytoplasmic calcium 
concentration changes (Westerblad and Allen, 1993), and it has been suggested that there 
is a positive relation between the recruitment frequency of muscle fibres and the amount of 
CaMKII activity developed during the period of muscle recruitement (Chin, 2005).  
This idea is supported by the finding that high (80% VO2max), but not low (40% 
VO2max) intensity cycling exercise increased phosphorylation of CaMKII at Thr287 
immediately after exercise (Egan et al., 2010). Presumably, the higher muscle power 
output required for cycling at 80% VO2max was at least in part due to increased motor unit 
firing frequencies. However, when higher power outputs are required, it is likely that a 
larger number of motor units is recruited (MacIntosh et al., 2000, Beltman et al., 2004) and 
therefore a different percentage of muscle fibres may be active at the site of the biopsy 
compared to the low intensity condition, which could affect the outcome of such studies.  
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Of further importance is whether CaMKII activity remains elevated after exercise 
or is turned off. Autonomous CaMKII activity could theoretically outlast the calcium 
signal, but even during continued electrical stimulation this activity can be reduced within 
seven minutes in skeletal muscle (Rose et al., 2007a). A high-intensity cycling protocol 
resulted in increased levels of phospho
Thr287
-CaMKII in m. vastus lateralis “immediately” 
after exercise, but these levels had returned to the pre-exercise values at three hours post-
exercise (Egan et al., 2010, Benziane et al., 2008). It is unknown how long CaMKII 
phosphorylation remained elevated after exercise in these studies.  
Finally, the consequences of the differences in calcium kinetics and concentration 
changes between slow- and fast-twitch muscles are unknown. Calcium transients in fast-
twitch muscle rise faster, have a higher amplitude (20 µM vs. 10 µM) and decay faster 
(Baylor and Hollingworth, 2003). It has been hypothesised that, due to the slow kinetics of 
CaMKII activation relative to those of calcium concentration changes, the difference 
between slow- and fast-twitch fibres would not have significant effects on CaMKII 
signalling (Tavi and Westerblad, 2011). However, this has not been tested experimentally.   
To investigate whether CaMKII acts as a ‘decoder’ of calcium signals in skeletal 
muscle, we kept in situ stimulated muscles below slack length (i.e. left of the ascending 
limb of the force-length relationship) to uncouple the calcium influx from force 
production. We investigated whether CaMKII was differentially phosphorylated at Thr287 
after high and low frequency stimulation. Because it is not known if the different CaMKII 
isoforms are differently activated by muscle stimulation, we analysed their 
phosphorylation separately. We stimulated three separate muscle compartments, slow-
twitch m. soleus (SOL) and fast-twitch oxidative (GMR) and glycolytic (GMW) 
m.gastrocnemius in our experiments to assess whether effects of stimulation differ between 
different fibre types. To investigate whether phosphorylation of the CaMKII isoforms 
remains elevated after muscle stimulation, we measured its time course after repeated 
tetanic contractions, which is thought to further activate CaMKII in rat GM (Rose et al., 
2007a) 
 
We hypothesised that  
1) Phospho
Thr287
-CaMKII levels are higher after stimulation with pulses at 150 Hz 
compared to stimulation with the same number of pulses at 10 Hz.  
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2) Phospho
Thr287
-CaMKII levels would increase more in the low oxidative GMW compared 
to high-oxidative GMR and SOL. 
3) Phospho
Thr287
-CaMKII levels are increased in stimulated muscle compared to non-
stimulated muscle at 10 minutes, but not at 60 minutes after the end of stimulation.  
 
Methods 
Animals 
Three month-old female Wistar rats (Harlan Laboratories; two-minute isometric 
contraction experiment: 191-230 grams, n=20; slack contraction experiment: 205-220 
grams, n=12) were anaesthetised initially by intraperitoneal injections of 1.2 ml/100 gram 
body weight of 12.5% urethane. Ear and foot reflexes were tested to check whether the 
animal was sufficiently anaesthetised. Subsequent injections of 0.3-0.5 ml, up to a 
maximum of 1.5 ml, were given every 10 minutes afterwards until reflexes had 
disappeared. Rats were kept on a heated pad (±37 ºC) to prevent hypothermia. 
 
Muscle-tendon preparation   
Hind limbs were shaved and skin was removed, after which m. gastrocnemius medialis 
(GM) and m. soleus  (SOL) were exposed and mechanically isolated by removing as much 
as possible the myofascial connections to surrounding muscles. Blood supply to and nerve 
innervations of SOL and GM were kept intact. The calcaneus was cut from the talus, while 
still attached to the Achilles tendon. The sciatic nerve was dissected free, proximally 
severed and electrically stimulated through an external electrode controlled by a computer 
(50µs rectangular pulses).  
 
Contraction protocols 
Effect of low and high frequency stimulation at short muscle length on phospho
Thr287
-
CaMKII levels 
 Experiments were performed at room temperature (23ºC). Muscles were kept below slack 
length because the used different stimulation frequencies would result in different muscle 
forces and energy consumption patterns if the muscles were kept at optimum length. Rats 
were divided into two groups: 1) GM and SOL stimulated at 10 Hz.  2) GM and SOL 
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stimulated at 150 Hz stimulation. Muscles of the right leg were stimulated. As CaMKII is 
phosphorylated within seconds after the start of contraction (Rose et al., 2007a) both 
groups received a total of 100 pulses (stimulation current: 3mA; pulse duration: 50 µs). 
The total duration of stimulation was 10 seconds for the 10 Hz group and 0.67 seconds for 
the 150 Hz group). After stimulation, GM and SOL were dissected as rapidly as possible 
and snap-frozen in liquid nitrogen. The first muscle was typically sampled after 1 minute, 
the second after 2 minutes. In half of the experiments, SOL was sampled first, and in the 
other half GM was sampled first. Subsequently, the non-stimulated left muscles were 
dissected and snap-frozen. Rats were killed by intracardial injection of Euthasol® while 
fully anaesthetised. Muscles were stored at -80°C until used for western blot analysis. 
 
Time course of CaMKII phosphorylation after muscle contractions 
The temperature of GM was kept at approximately 35°C using an envelope into which 
warm water vapour was sprayed. The Achilles tendon was tied to a Kevlar thread, which 
was subsequently attached to a force transducer. Force data were sampled at a frequency of 
1000 Hz. Optimum muscle length (the length of the muscle-tendon complex at which 
maximum tetanic force was produced) was estimated using twitches, and subsequently 
determined using 3-4 tetanic contractions. GM rested for two minutes between each tetanic 
contraction and for 15 minutes after determination of optimum length. A stimulation 
protocol consisting of a series of 24 pulse trains was then applied (stimulation current: 
3mA; pulse duration: 50 µs), resulting in tetanic maximal isometric contractions 
(stimulation frequency: 150Hz; 1 train every 5 s; train duration: 200 ms). This protocol 
resulted in a decrease in maximal tetanic force of approximately 30% (Fig. 1)   
 
 
Figure 1: Decrease in tetanic force during 
the ‘two-minute isometric’ contraction 
protocol 
Data are displayed as means ±SEM. Note that 
the error bars are barely visible because they 
are often smaller than the symbols indicating 
the mean relative titanic force.    
 
 
24 
 
Five groups of muscles were defined by the time point of sampling: 1) resting; 2) optimum 
length determination (LOPT; 3) two minutes after the contraction protocol; 4) 10 minutes 
after the contraction protocol; 5) 60 minutes after the contraction protocol (Fig. 2). At the 
defined time points, GM was dissected and snap-frozen in liquid nitrogen. Animals were 
killed by intra-cardiac injection of Euthasol®, while still fully anaesthetised. Frozen 
muscles were stored at -80ºC until used for western blotting. 
 
 
  
 
Figure 2: Experimental design of the ‘two-minute isometric’ contraction protocol. 
Left and right m. gastrocnemius medialis of the animals were randomly assigned to one of five groups: rest, 
LOPT, 2 min post, 10 min post or 60 min post. The imposed stimulation and periods of rest following 
stimulation are described in this figure. Details of the ‘2 min isometric contractions’ protocol can be found in 
the methods section. At the end of the prescribed stimulation protocol/resting period, the muscles were 
dissected and frozen in liquid nitrogen.   
 
 
Protein analysis 
Frozen muscle was cut into 25 µm thick cross-sections in a cryostat, which were collected 
in a 2 ml tube and kept at -20ºC. Chemicals were obtained from Sigma-Aldrich (Poole, 
United Kingdom) unless stated otherwise.  Ice-cold RIPA buffer (50mM TRIS-HCl (pH 
7.5), 150mM NaCl, 1mM EDTA, 1% v/v Non-Idet P40 substitute, 0.25% w/v sodium 
deoxycholate plus freshly added protease/phosphatase inhibitors: 1 mM NaF, 1 mM 
Na3VO4, 0.1 mM PMSF, 1µg/ml leupeptin, 0.2 µg /ml pepstatin, 0.1 µg/ml aprotinin) was 
then added and sections were homogenised on ice using a Polytron homogeniser 
(Kinematica AG, Luzern, Switzerland). Crude homogenates were aspirated 5-10 times 
through a 0.8 mm syringe needle, and stored at -80ºC until use for analysis. An aliquot of 
the aspirated homogenate was taken for determination of protein concentration with the 
bicinchoninic acid protein assay (Pierce, Rockford IL, USA). 
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Protein levels of total CaMKII, phospho
Thr287
-CaMKII and cytochrome-c oxidase 
subunit IV (COXIV) were analysed by western blotting followed by immunodetection. 
Homogenates were denatured by addition of sample buffer (final concentration: 50mM 
TRIS-HCl (pH 6.8), 2% w/v SDS, 10% v/v glycerol, 2% β-mercaptoethanol) and 5 
minutes heating at 95ºC. 20 µg of protein was separated by SDS-PAGE and transferred 
overnight onto a nitrocellulose membrane (GE Healthcare Life Sciences, Little Chalfont, 
United Kingdom), while transfer buffer was cooled in ice. Membranes were stained with 
Ponceau S solution to confirm equal protein loading and transfer. The stain was washed off 
with TRIS-buffered saline with tween-20 (TBS-T; 20mM TRIS-HCl (pH 7.5), 0.9% w/v 
NaCl, 0.05% Tween-20) and the membrane was blocked in antibody incubation solution, 
followed by incubation with a primary antibody for either pan-CaMKII (BD Bioscience, 
#611292, dilution: 1/2500), phospho
Thr287
-CaMKII (Cell Signalling Technology #3361, 
dilution: 1/1000) or COXIV (Cell Signalling Technology, #4850, dilution 1/2000) for two 
hours. Antibody incubation solutions were 5% milk in TBS-T (for pan-CaMKII) or 5% 
bovine serum albumin (BSA) in TBS-T (for phospho
Thr287
-CaMKII). Residual antibody 
was washed away with 4 washes of 5 minutes in TBS-T, followed by incubation with 
species-specific horseradish peroxidase-conjugated secondary antibodies. Antibodies were 
detected with an enhanced chemiluminescence kit (Pierce, Rockford IL, USA). Light 
signals were captured with a ChemiDoc XRS system (Biorad, Hemel Hempstead, United 
Kingdom).  
Samples from all experimental groups from the in situ contraction experiments 
were analysed on the same blot, so direct comparisons of protein expression could be 
made. Protein bands were quantified with Quantity One version 4.6.8 (Biorad). 
Background-corrected band intensities on each blot were normalized to the sum of the 
intensities of the same band in all lanes to correct for differences in overall staining 
intensity of the blots. The obtained values were related to the mean of the ‘rest’ group.  
 
In vitro CaMKII phosphorylation 
To ensure specificity of the phospho
Thr287
-CaMKII antibody in our setup and to detect 
calcium/calmodulin-sensitive protein bands, CaMKII was phosphorylated in vitro by 
incubating 5 µl of crude muscle homogenate with a reaction mix containing 
calcium/calmodulin (Enzo Life Sciences, Exeter, United Kingdom) (total volume: 50 µl; 
0.1 mM ATP, 10 mM HEPES (pH 7.4), 5 mM MgCl2, 0.1% Tween-20 and 0.5 mM CaCl2 
26 
 
+ 1 µM calmodulin or 5 mM EGTA) for 30 minutes at 30ºC. The reaction was stopped by 
the addition of 16.7 µl 4x sample buffer. Samples were heated to 95 ºC and proteins were 
separated with SDS-PAGE on a 15% acrylamide (Biorad) gel and subjected to western 
blotting as described. Based on data from (Bayer et al., 1998), we  identified the detected 
CaMKII bands as βM (72 kDa), δA (60 kDa) and a combination of δD and γB (58 kDa).        
 
Muscle compartments  
Red and white portions of GM (GMR and GMW, respectively), which contains 
compartmentalised fibres with high or low oxidative capacity (De Ruiter et al., 1995), were 
analysed separately. Tissue from GMR or GMW was obtained by cutting cryosections 
from the proximal or distal end of the frozen muscle, respectively.     
 
Statistics 
Slack contraction protocol 
The effect of stimulation on total and phospho
Thr287
-CaMKII levels was tested with 
factorial ANOVAs (stimulation x frequency), with repeated measures on the factor 
stimulation. The effect of stimulation frequency was tested by assessing the interaction 
between stimulation and frequency.  These tests were performed separately for GMR, 
GMW and SOL. We expected phospho
Thr287
-CaMKII to increase in stimulated muscles 
(Rose et al., 2007a). Therefore, one-sided post-hoc tests were carried out to analyse the 
effect of stimulation on phospho
Thr287
-CaMKII. Comparisons between muscles stimulated 
at a specific frequency and their intra-animal resting controls were made with Wilcoxon 
signed ranks tests. 
 
Two-minute isometric contraction protocol.    
The effect of stimulation on total and phospho
Thr287
-CaMKII levels was tested with 
Kruskal-Wallis ANOVAs for GMR and GMW. Mann-Whitney U-tests were used to test 
differences between individual time points within one compartment and Wilcoxon signed 
ranks tests were used to test differences between compartments at one specific time point. 
Correlations between COXIV and phospho
Thr287
-CaMKII were tested with Spearmon’s 
Rho. Significance level was set at p≤ 0.05.  
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Results 
 
The acute effects of stimulation frequency on total and phospho
Thr287
-CaMKII in GM 
and SOL 
We investigated CaMKII phosphorylation in GMR, GMW and SOL after stimulation with 
100 pulses at 10 or 150 Hz. In GMR, we observed a significant increase in phospho
Thr287
-
CaMKII for the δA and δD/γB, but not for the βM isoform (βM: p=0.066; δA: p=0.048; δD/γB: 
p= 0.050). In GMW, we observed a significant increase in δA only (βM: p=0.114; δA: 
p=0.043; δD/γB: p= 0.447), whereas in SOL none of the phospho
Thr287
-CaMKII isoforms 
was significantly increased (Fig. 3). We did not observe an interaction effect between 
stimulation and frequency on phospho
Thr287
-CaMKII in GMR, GMW or SOL.  
 
Surprisingly, we observed a decrease in total CaMKII in GMW after 150 Hz stimulation 
(Wilcoxon signed ranks test; βM: p=0.03, δA: p=0.44, δD/γB: p=0.03), but not after 10 Hz 
stimulation (stimulation x frequency interaction: βM: p=0.03, δA: p=0.22, δD/γB: p=0.03) 
(Fig. 4). Such a decrease was not observed in GMR or SOL (Fig. 4). 
 
For all muscles, there was no difference in actin levels on the blots between resting and 
stimulated samples (GMR: p=0.21; GMW: p=0.22; SOL: p=0.40) and no statistical 
interaction effect between stimulation and frequency on actin levels (GMR: p=0.47; 
GMW: p=0.72; SOL: p=0.52) (Appendix, Fig. A1).  
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Figure 3: Phospho
Thr287
-CaMKII levels in rat m. gastrocnemius medialis and m. soleus samples after 
slack contractions.  
Graphs display phospho
Thr287
-CaMKII levels for βM, δA and δD/γB as determined by western blotting followed 
by immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: SOL, βM-CaMKII; D: GMR, δA-
CaMKII; E: GMW, δA-CaMKII; F: SOL, δA-CaMKII; G: GMR, δD/γB-CaMKII; H: GMW, δD/γB-CaMKII; I: 
SOL, δD/γB-CaMKII. Bars represent mean phospho
Thr287
-CaMKII levels and symbols represent the amount of 
phospho
Thr287
-CaMKII in individual muscles. Same symbols represent muscles from the same animal within 
one frequency group. Muscles connected by a dashed line are intra-animal pairs. Note the different scales of 
different graphs. GMR = High oxidative, (red) m. gastrocnemius medialis. GMW = low oxidative (white) m. 
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gastrocnemius medialis. SOL = m. soleus.  Rest- xxHz denotes non-stimulated muscle, contra-lateral to the 
muscle stimulated at xx Hz which is denoted by Stim – xxHz. Significance of stimulation effect is indicated 
in each graph. A.U. = arbitrary units. Examples of phospho
Thr287
-CaMKII immunoblots and poncesu s-stained 
actin bands are shown below the graphs. J: GMR; K: GMW; L: SOL.      
 
 
 
 
Figure 4: Decrease in total CaMKI in rat white m. gastrocnemius medialis after slack contractions. 
Graphs display total CaMKII levels for βM, δA and δD/γB as determined by western blotting followed by 
immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: SOL, βM-CaMKII; D: GMR, δA-
CaMKII; E: GMW, δA-CaMKII; F: SOL, δA-CaMKII; G: GMR, δD/γB-CaMKII; H: GMW, δD/γB-CaMKII; I: 
SOL, δD/γB-CaMKII. Bars represent mean total CaMKII levels and symbols represent the amount of total 
CaMKII in individual muscles. Same symbols represent muscles from the same animal within one frequency 
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group. Muscles connected by a dashed line are intra-animal pairs. Note the different scales of different 
graphs. GMR = High oxidative, (red) m. gastrocnemius medialis. GMW = low oxidative (white) m. 
gastrocnemius medialis. SOL = m. soleus.  Rest- xxHz denotes non-stimulated muscle, contra-lateral to the 
muscle stimulated at xx Hz which is denoted by Stim – xxHz. Significance of stimulation effect is indicated 
in each graph. A.U. = arbitrary units. Examples of total CaMKII immunoblots and ponceau s-stained actin 
bands are shown below the graphs. J: GMR; K: GMW; L: SOL.      
 
The effect of two-minute isometric contractions on total and phospho
Thr287
-CaMKII 
in red and white GM compartments 
We investigated CaMKII phosphorylation in the two compartments of GM after a two-
minute isometric protocol. For both compartments, we did not observe a significant main 
effect of stimulation on phospho
Thr287
-CaMKII for any of the isoforms (GMR: βM: p=0.33, 
δA: p=0.09, δD/γB: p=0.157; GMW: βM: p=0.91, δA: p=0.75, δD/γB: p=0.27). When the 
mean phospho
Thr287
-CaMKII levels at the time points at which these were highest for each 
CaMKII isoform were compared to phospho
Thr287
-CaMKII levels in the resting muscles, 
we only observed a trend for an increase in the δA isoform in GMR after the contractile 
activity necessary to determine the optimum length (Fig. 5). 60 Minutes after stimulation, 
phospho
Thr287
-CaMKII levels tended to be decreased for βM and δA isoforms compared to 
the time point at which mean phospho
Thr287
-CaMKII levels were highest (Fig. 5). No 
significant differences in phospho
Thr287
-CaMKII between individual time points were 
observed for any of the isoforms in GMW.  
 
All isoforms showed higher phospho
Thr287
-CaMKII levels in rested GMW compared to 
rested GMR (Main effect of compartment: βM: p<0.01, δA: p<0.01, δD/γB: p=0.01) (Fig. 5). 
This difference was significant in the resting muscles for the βM (p=0.02) and δA (p=0.03) 
isoforms, and was associated with a higher aerobic capacity in GMR, as reflected by a 
higher COXIV protein expression in GMR (p=0.03; Fig. 6). There was no difference in 
total CaMKII in rested muscles (Fig. 7).  
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Figure 5: Phospho
Thr287
-CaMKII in rat m. gastrocnemius medialis samples before and after a two-
minute isometric contraction protocol.  
Graphs display phospho
Thr287
-CaMKII levels as determined by western blotting followed by 
immunodetection. A: GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: GMR, δA-CaMKII; D: GMW, δA-
CaMKII. E: GMR, δD/γB-CaMKII; F: GMW, δD/γB-CaMKII. Bars represent mean phospho
Thr287
-CaMKII 
levels and symbols represent the amount of phospho
Thr287
-CaMKII in individual samples. Amounts are 
relative to the mean of the resting GMR samples. The dashed line represents the mean level of phospho
Thr287
-
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CaMKII in the resting GMR samples.G: Examples of immunoblot for phospho
Thr287
-CaMKII in GMR and 
GMW, and ponceau s-stained actin bands. A.U. = arbitrary units. GMR = High oxidative (red) m. 
gastrocnemius medialis. GMW = low oxidative (white) m. gastrocnemius medialis. 
 
 
 
 
Figure 6: COXIV protein expression in oxidative and glycolytic m. gastrocnemius   
A: Graph displays COXIV levels as determined by western blotting followed by immunodetection. Bars 
represent mean COXIV levels and symbols represent the amount of COXIV in individual samples. Muscles 
connected by a dashed line are intra-animal pairs. Significance of the difference between red and white GM 
is indicated. B: Example COXIV immunoblot is shown below the graph. R = red GM; W = white GM. 
 
  
 
Total CaMKII was significantly decreased after stimulation in GMW (Main effect of 
stimulation: βM: p<0.01, δA: p=0.04, δD/γB: p=0.04), but not in GMR (βM: p=0.13, δA: 
p=0.89, δD/γB: p=0.49) (Fig. 7).   
 
There were no differences in actin levels on the blots (GMR phospho
Thr287
-CaMKII blots: 
p=0.80; GMR, total CaMKII blots: p=0.96; GMW, phospho
Thr287
-CaMKII blots: p=0.99; 
GMW, total CaMKII blots: p=0.94; Appendix, Fig. A2), indicating equal protein loading 
in all conditions. 
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Figure 7: Total CaMKII in rat m. gastrocnemius medialis samples before and after a two-minute 
isometric contraction protocol.   
Graphs display total CaMKII levels as determined by western blotting followed by immunodetection. A: 
GMR, βM-CaMKII; B: GMW, βM-CaMKII; C: GMR, δA-CaMKII; D: GMW, δA-CaMKII. E: GMR, δD/γB-
CaMKII; F: GMW, δD/γB-CaMKII. Bars represent mean total CaMKII levels and symbols represent the 
amount of total CaMKII in individual samples. Amounts are relative to the mean of the resting GMR 
samples. The dashed line represents the mean level of total CaMKII in the resting GMR samples. P-values in 
the figure indicate significance of the difference compared to the ‘rest’ group. G: Examples of immunoblot 
for total CaMKII in GMR and GMW and ponceau s-stained actin bands. A.U. = arbitrary units. GMR = High 
oxidative (red) m. gastrocnemius medialis. GMW = low oxidative (white) m. gastrocnemius medialis. 
 
 
Discussion  
 
Main results  
Our results suggest that stimulation of GM with 100 twitch pulses can increase 
autophosphorylation of CaMKII (Fig. 3). However, in contrast to our hypothesis, we did 
not observe significant differences in phospho
Thr287
-CaMKII after low and high frequency 
stimulation (Fig. 3). We observed higher basal phospho-CaMKII levels in GMW compared 
to GMR (Fig. 5). Finally, we observed an unexpected decrease in total CaMKII in GMW 
after high-frequency stimulation (Fig. 4 & Fig. 7).  
 
Technical considerations 
After both the ‘two minute isometric contraction’ protocol and ‘slack contraction’ protocol 
we observed a large variability in phospho
Thr287
-CaMKII levels in SOL and GM 
compartments (Fig. 3 & Fig. 5). Autophosphorylation of CaMKII at Thr287 occurs only 
when two Ca
2+
/CaM-bound subunits interact (Hanson et al., 1994, Rich and Schulman, 
1998). Autophosphorylation increases Ca
2+
/CaM affinity many fold (Meyer et al., 1992) 
and therefore, small differences in the fraction of autophosphorylated CaMKII subunit 
could lead to large differences in the rate of autophosphorylation. In vitro, it has been 
demonstrated that the development of autonomous CaMKII activity displays very high 
sensitivity to changes in [Ca
2+
] when interacting with protein phosphatase 1 (PP1) 
(Bradshaw et al., 2003). It may be that variability in intracellular [Ca
2+
] in our experiments 
contributed to the observed variation in phospho
Thr287
-CaMKII.    
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Some non-stimulated samples had higher phospho
Thr287
-CaMKII levels compared to 
the average level in stimulated samples (Fig. 3 & Fig. 5). This indicates that factors other 
than muscle stimulation affect phospho
Thr287
-CaMKII levels in skeletal muscle. Our 
observation that resting phospho
Thr287
-CaMKII was higher in GMW compared to that in 
GMW suggests that the level of phospho
Thr287
-CaMKII is related to the oxidative capacity 
of the muscle. However, we did not observe a significant correlation between 
phospho
Thr287
-CaMKII and COXIV protein levels within these compartments (GMR: 
Rho=0.27; GMW: Rho=0.33), suggesting that the variation in phospho
Thr287
-CaMKII 
levels cannot be explained by differences in oxidative capacity within the GM 
compartments. 
Auto-phosphorylation of CaMKII at Thr287 is not the only mechanism that 
regulates the activity of the kinase. Ca
2+
/CaM-dependent activity may play an important 
role in intracellular signalling. Furthermore, kinase activation is also regulated by 
autophosphorylation of Thr306/307. These residues are in the CaM-binding domain and 
their phosphorylation inhibits CaM binding to this domain (Hanson and Schulman, 1992, 
Colbran, 1993). Finally, Met281/282 of CaMKII can be oxidized, which is a parallel 
mechanism of activation to autophoshorylation at Thr287 (Erickson et al., 2008). Although 
a previous study has found that levels of phospho
Thr287
-CaMKII and autonomous CaMKII 
activity correlated quite well in rat skeletal muscle (Rose et al., 2007a), it is possible that 
the levels of phospho
Thr287
-CaMKII in our study do not perfectly reflect CaMKII activity.    
 
Implications for CaMKII-signalling in skeletal muscle  
We observed lower phospho
Thr287
-CaMKII levels in the red compared to the white 
compartment of GM (Fig. 5). Basal phosphorylation levels of mitogen-activated protein 
kinases p38, p42 and p44, and AMP-activated protein kinase (AMPK) have also been 
shown to be lower in the ‘red‘, compared to the ‘white’ rat m. tibialis anterior 
compartment (Ljubicic and Hood, 2008). Autophosphorylation at Thr287 increases the 
affinity of CaMKII for Ca
2+
/CaM manyfold (Meyer et al., 1992). Therefore, Ca
2+
-CaM-
dependent CaMKII activity in GMW may be sensitised to changes in [Ca
2+
]i.  
CaMKII has been implicated as a regulator of the ‘slow oxidative’ muscle 
phenotype (Mu et al., 2007) and mitochondrial biogenesis (Wright et al., 2007). However, 
slow-twitch m. soleus was the only muscle compartment in which none of the CaMKII 
isoforms displayed increased autophosphorylation in response to the slack contraction 
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protocol. Furthermore, GMW has a higher level of phospho
Thr287
-CaMKII than GMR (Fig. 
5). These results suggest a negative association of CaMKII-signalling with features of the 
slow-oxidative phenotype. Possibly, the lower amplitude of calcium concentration changes 
in m. soleus compared to m. gastrocnemius medialis (Baylor and Hollingworth, 2003) can 
explain the absence of an increase in CaMKII autophosphorylation in SOL, which could be 
reflective of the effect of training on acute CaMKII signalling. Similarly, it has been shown 
that AMPK activation is attenuated in trained skeletal muscle, and that this is associated 
with a reduction in the activating signal (i.e. the AMP: ATP ratio) after training (McConell 
et al., 2005). Training-induced changes in muscle phenotype may have a similar effect on 
CaMKII signalling by altering calcium cycling in skeletal muscle (Green et al., 2003). In 
contrast to this hypothesis, CaMKII autophosphorylation in human skeletal muscle was not 
attenuated after a 10 day exercise training program (Benziane et al., 2008). However, this 
training protocol was possibly not sufficient to induce changes in the expression of 
calcium-regulatory proteins.   
We found no evidence for an effect of motor unit recruitment frequency on 
phospho
Thr287
-CaMKII levels (Fig. 3). It is possible that the recruitment frequencies used in 
this study and those occurring in skeletal muscle in vivo are too high to be converted into 
differing amounts of autonomous kinase activity. In vitro, frequency-dependence of 
CaMKII autophosphorylation was shown for frequencies between 1 and 4 Hz (De Koninck 
and Schulman, 1998). However, the duration of these pulses was much longer than the 
duration of a Ca
2+
 pulse in fast- and slow-twitch skeletal muscle fibres (200 ms vs. 50-100 
ms (Baylor and Hollingworth, 2003)), and decreasing the duration of the Ca2+-pulse 
shifted the frequency-autonomous activity relation towards higher frequencies (De 
Koninck and Schulman, 1998). Thus, although CaMKII might be differentially activated 
by in vivo-relevant muscle recruitment frequencies, this is not exhibited in skeletal muscle 
after electrical stimulation.   
Our data indicate that phospho
Thr287
-CaMKII decreases during a one-hour time 
course after cessation of stimulation (Fig. 5). Combining results from the slack 
experiments (Fig. 3) and the two-minute isometric contraction protocol (Fig. 5) suggests 
that increases in phospho
Thr287
-CaMKII are detectable within the first two minutes after 
contraction but not after 15 minutes. Different protein phosphatases (PP1, PP2A, PP2C) 
can de-phosphorylate Thr286 (the alpha-CaMKII homologue of Thr287) in rat forebrain 
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neurons (Strack et al., 1997), and as these are also expressed in skeletal muscle (Cohen, 
1989), they may play a role in regulating CaMKII phosphorylation in skeletal muscle.  
 
Muscle phenotype-specific decrease in total CaMKII  
In both the slack contraction experiment and the two-minute isometric contractions 
protocol, total CaMKII was decreased in GMW after stimulation with pulses at 150 Hz, but 
not with 10 Hz stimulation (Fig. 4 & Fig. 7). The stimulated samples in the slack 
experiment were always sampled before the resting controls. This suggests the decrease in 
total CaMKII was due to factors related to stimulation, and were not an artifact of the 
experimental setup.   
This raises the question as to what caused the decrease in total CaMKII in white 
GM. Given the time frame in which this effect occurred, there are three potential 
explanations: 1) A post-translational modification of the protein reduced the antigenicity of 
the CaMKII antibody for its epitope, or binding to the membrane during blotting. 2) 
Translocation of CaMKII to a non-soluble subcellular fraction, which prevented it from 
entering the gel during SDS-PAGE. 3) Degradation of CaMKII. The last option cannot 
explain the acute decrease in total CaMKII observed in GMW during the slack experiment, 
but degradation of CaMKII could be partially involved in explaining the difference 
between total CaMKII levels 60 minutes post-stimulation compared to that of resting 
muscle (Fig. 7).  
Currently, no posttranslational modifications of CaMKII are known in the 
association domain of the protein, which is where our CaMKII antibody binds according 
the specifications given by the manufacturer (immunogen: rat alpha CaMKII aminoacids 
448-460). In neurons, CaMKII has been shown to be able to translocate to different 
compartments of the cell upon stimulation by Ca
2+
/CaM (Bayer and Schulman, 2001). 
However, whether this occurs in muscle, what the target binding sites are, and whether 
these fractions would not be solubilised in our protein extraction procedure, is unknown. It 
should be noted that our protocol did solubilise and separate the βM isoform, which is 
targeted to the SR membrane via anchoring protein αKAP (Bayer et al., 1998). 
Finally, degradation of CaMKII protein might have occurred. The Ca
2+
-dependent 
protease µ-calpain can degrade CaMKII into 30-35 kDa fragments (Hajimohammadreza et 
al., 1997, Yoshimura et al., 1996), and mice overexpressing the calpain-inhibitor 
calpastatin have increased CaMKII protein levels (Otani et al., 2006). These studies 
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indicate that CaMKII is subject to degradation by calpains in skeletal muscle. We have 
found no evidence of immunoreactive bands on our western blots with an approximate 
molecular weight of 30-35 kDa. It is therefore unclear what caused the observed decrease 
in total CaMKII in GMW.  
Note that in previous experiments in which rat GM was stimulated in situ a 
decrease in total CaMKII was not detected (Rose et al., 2007a). However, in this study red 
and white GM were not separately analysed, whereas our data suggest that muscle 
phenotype has a significant effect on the decrease in detected total CaMKII.   
 
Conclusion 
Our results suggest that CaMKII can be autophosphorylated by a short contraction 
protocol, but that this phosphorylation is only detectable within 15 minutes after 
contraction. Furthermore, other factors than stimulation appear to strongly affect CaMKII 
phosphorylation. We detected a decrease in total CaMKII after high-frequency stimulation 
in fast glycolytic muscle. Therefore, investigations into interactions of other factors than 
Ca
2+
/CaM with CaMKII signalling in skeletal muscle are warranted.  
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Appendix: Western blot loading controls 
 
 
 
 
 
 
 
Figure A1: Western blot loading controls for ‘slack contraction’ experiments 
Graphs displaying quantifications of ponceau s-stained actin on blots of muscle samples from the ‘slack 
contraction’ experiment. Data are displayed as means ± S.E.M. Note that the graphs have different scales. 
GMR = High oxidative (red) m. gastrocnemius medialis. GMW = Low oxidative (white) m. gastrocnemius 
medialis. SOL = m.soleus. 
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Figure A2: Western blot loading controls for ‘2 minutes isometric contraction’ experiments 
Graphs displaying quantifications of ponceau s-stained actin on blots of muscle samples from the ‘2 minutes 
isometric contraction’ experiment. Data are displayed as means ± S.E.M. GMR = High oxidative (red) m. 
gastrocnemius medialis. GMW = Low oxidative (white) m. gastrocnemius medialis.  
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Chapter 3: Ca
2+
/calmodulin-dependent protein kinase II affects 
contractile, but not fatigue-related phenotype in rat skeletal muscle 
 
 
Abstract 
 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is the main CaMK in skeletal 
muscle and its expression increases with endurance training. Because CaMKII has been 
implicated as a regulator of mitochondrial biogenesis and calcium handling, we 
investigated the effects of acute CaMKII overexpression in skeletal muscle in vivo. We 
overexpressed α/β-CaMKII in adult rat m. gastrocnemius (GM) and m. soleus (SOL) via 
gene electro-transfer. CaMKII overexpression did not alter cytochrome c oxidase IV 
(COXIV) protein levels in either GM or SOL. Likewise, mRNA levels of oxidative 
phosphorylation components COXIV, COXI and the transcriptional coactivator PGC-1α 
were not different between empty- and CaMKII-transfected m. soleus, whereas succinate 
dehydrogenase subunit b mRNA was decreased in CaMKII-transfected m. soleus (-26%, 
p<0.05). Force parameters of transfected muscles were measured in situ with intact 
innervations and perfusion. Strength and fatigue resistance of control- and CaMKII-
transfected soleus and gastrocnemius did not differ. However, CaMKII overexpression 
decreased twitch time-to-peak force (p<0.05) and half-relaxation time (p<0.05). In 
addition, CaMKII-overexpressing m. soleus fibres displayed increased sarco/endoplasmic 
reticulum Ca
2+
-ATPase 2 expression compared to non-transfected fibres (p<0.001). Our 
results suggest that CaMKII is not sufficient for mitochondrial biogenesis, but regulates the 
contractile muscle phenotype.   
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Introduction  
 
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a multimeric 
phosphotransferase which can decode calcium transients through autophosphorylation at 
threonine287 (De Koninck and Schulman, 1998). In heart muscle cells, CaMKII is known 
to control ion channels and gene expression (Anderson et al., 2011). In skeletal muscle, 
CaMKII has been shown to be the main multifunctional CaMK and its phosphorylation at 
threonine287 and activity are increased during acute exercise bouts in rats and humans 
(Rose et al., 2007a, Rose et al., 2006). CaMK activation has been implied to regulate 
mitochondrial biogenesis (Wu et al., 2002, Ojuka et al., 2003, Wright et al., 2007) and 
calcium re-uptake into the sarcoplasmic reticulum (SR) via a possible effect on SERCA2 
(Hawkins et al., 1994). This, and the observation that endurance exercise training increases 
total CaMKII protein expression (Benziane et al., 2008, Rose et al., 2007b) suggest a role 
for CaMKII in the control of muscle plasticity.  
 Our current understanding of the physiological role of native CaMKII holoenzymes 
in whole muscle is limited, as it has been mainly derived from the characterisation of the 
effects of germline overexpression of a constitutively active CaMKIV mutant (Wu et al., 
2002), which has lost its calcium-dependent regulation, and is not expressed in skeletal 
muscle (Akimoto et al., 2004). Furthermore, our current understanding of the role of 
CaMKII in calcium handling and fatigue in skeletal muscle is derived from in vitro studies 
(Hawkins et al., 1994) and short-term inhibition studies with pharmacological agents in 
single muscle fibres (Tavi et al., 2003). However, skeletal muscle fibres exist as a 
continuum of contractile phenotypes with distinct differences in calcium handling (Baylor 
and Hollingworth, 2003) and recruitment patterns (Hennig and Lomo, 1985). This 
indicates that pronounced differences in CaMKII-mediated calcium sensing and 
downstream effects may exist between functionally distinct muscle types.  
We hypothesised that hetero-multimeric CaMKII controls the mitochondrial and 
contractile phenotype of skeletal muscle via regulation of gene expression, and that this 
would differ between a slow-twitch and fast-twitch muscle of the lower leg (i.e. m. soleus 
(SOL) and m. gastrocnemius (GM)), due to differences in fibre recruitment in these 
muscles during self-initiated locomotion (Gorassini et al., 2000). We tested this by 
assessing the effects of somatic co-overexpression of native alpha- and beta-CaMKII 
isoforms, with similar substrate specificity and structure as the muscle isoforms  
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(Woodgett et al., 1984, Gaertner et al., 2004), on selected molecular markers of the 
contractile and mitochondrial phenotype, and functional characteristics of the targeted 
soleus and gastrocnemius medialis muscles. 
 
 
Methods  
 
Ethical approval 
A total of 23 female Wistar rats were used for the experiments described here. In situ 
contraction protocols and the majority of the transfection experiments were carried out at 
the MOVE Research Institute Amsterdam, VU University Amsterdam, The Netherlands 
and approved by the local Animal Experiments Committee. Two transfection experiments 
were carried out at the Department of Cardiovascular Surgery, University Hospital Bern, 
Switzerland and approved by the animal protection commission of the Canton of Berne, 
Switzerland. 
 
Somatic overexpression of CaMKII 
Plasmids 
PCDNA3 vectors encoding full-length cDNA for CaMKIIα and CaMKIIβ were a gift from 
Dr. M Neal Waxham (University of Texas, Houston, USA). PGL2 plasmid encoding full-
length luciferase under control of 424 basepairs upstream of the transcription start site of 
the chicken skeletal alpha-actin gene (Marsh et al., 1998) was a gift from Dr. Frank W. 
Booth (University of Missouri, Columbia, USA).   
 
Transfection 
Three month-old female Wistar rats (Harlan Laboratories/Charles River; 191-230 grams, 
n=13) were used to overexpress CaMKII in GM and SOL. The animals were anaesthetised 
with 2-4% isoflurane through inhalation. Hind limbs were shaved, and skin was disinfected 
with 70% ethanol. An incision was made into the skin and fascia between GM and m. 
tibialis anterior. SOL was subsequently exposed and liberated, after which four injections 
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of a plasmid mixture with a total volume of 90 µl were administered intramuscularly with a 
29-gauge insulin syringe. GM was administered four injections over the length of the 
muscle with a total volume of 180 µl. A mix of expression plasmid for full-length 
CaMKIIα (pCDNA3-CaMKIIα; 0.22 µg/µl) and full-length CaMKIIβ (pCDNA3-
CaMKIIβ; 0.22 µg/µl) in TBE buffer was injected into muscles of the right leg together 
with the -424 skeletal alpha-actin reporter plasmid (0.55 µg/µl). Data obtained from this 
reporter construct are beyond the scope of this chapter, and are therefore reported in a 
separate chapter. Muscles of the left leg were injected with the reporter plasmid only (1 
µg/µl). Right and left transfected muscles will henceforth be referred to as ‘CaMKII-
transfected’ and ‘control-transfected’, respectively. DNA injection was followed by 
electroporation with a GET42 electropulser (E.I.P. Electronique et Informatique du Pilat, 
Jonzieux, France). Needle electrodes were placed along SOL or into GM and pulse 
protocols were applied as described previously (Durieux et al., 2009). 
After electroporation, the skin wound was closed with sutures, and the animal was 
allowed to recover from anaesthesia. Animals were kept in cages afterwards, where they 
resumed normal activity within hours after surgery. After seven days, animals were 
anaesthetised for measurement of muscle contraction parameters (see below), sacrificed by 
intra-cardiac injection of Euthasol® (VU University Amsterdam) or anaesthetised with 3% 
isoflurane and euthanised by dislocation of the cervical vertebrae and rapid exsanguination 
(University Hospital Bern). Transfected muscles were harvested from both legs and snap-
frozen in liquid nitrogen. 
 
Muscle-tendon complex preparation  
For measurement of  isometric muscle contraction parameters, rats were anaesthetised by 
intra-peritoneal injections of 1.2 ml/100 gram body weight of 12.5% urethane (De Haan et 
al., 2003). Ear and foot reflexes were tested to check whether the animal was sufficiently 
anaesthetised. Subsequent injections of 0.3-0.5 ml, up to a maximum of 1.5 ml, were given 
every 10 minutes afterwards until reflexes had disappeared. Experiments were carried out 
at room temperature (24ºC). Rats were kept on a heated pad to prevent hypothermia. Hind 
limbs were shaved and skin was removed, after which GM and SOL were exposed and 
mechanically isolated by removing as much as possible the myofascial connections to 
surrounding muscles. Blood supply to, and nerve innervations of, both muscles were kept 
intact and tendons of GM and SOL were attached to a force transducer via Kevlar wires. 
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The sciatic nerve was severed proximally and received stimulation with rectangular pulses 
through an external electrode controlled by a computer. Force data were sampled at a 
frequency of 1000 Hz.  
 
Activation of exogenous CaMKII in transfected skeletal muscle 
A two-minute stimulation protocol consisting of either intermittent isometric tetanic 
contractions at 100Hz stimulation frequency (Rose et al., 2007a), or continuous stimulation 
at 10Hz was applied to α/β-CaMKII overexpressing GM and SOL in situ. The muscles 
(n=6) were freeze-clamped between liquid nitrogen-cooled aluminium grips during 
stimulation after two minutes. Non-stimulated, α/β-CaMKII overexpressing contra-lateral 
muscles were subsequently dissected and frozen in liquid nitrogen. Proteins were extracted 
from the muscle and subjected to SDS-PAGE followed by immunoblotting as described 
below. The phosphorylated form of exogenous β-CaMKII was identified based on its 
molecular weight (60.4 kDa), which is very similar to that of δa (60.1 kDa), the second 
largest CaMKII isoform in skeletal muscle (Bayer et al., 1998).  
 
In situ contraction protocol 
Optimum length of the muscle-tendon complex (the length of the muscle-tendon complex 
at which maximum force was produced) for isometric contractions was first estimated 
using twitches, then determined using a protocol consisting of two twitches and one tetanic 
contraction (pulse duration 100 µsec, tetanic stimulation frequency: 100 Hz, train duration: 
400 ms (De Haan et al., 1993)). Muscles were kept below slack length between 
contractions and rest duration between maximal contractions was approximately one 
minute. After determination of optimum length, muscles rested for five minutes. A high-
intensity contraction protocol (stimulation frequency: 100Hz; train duration: 300 ms, one 
train every 800 ms) was then applied to induce muscle fatigue (50 tetanic contractions, 
duration: 300 ms, rest interval: 500 ms) with muscles set to optimum length. GM and SOL 
were dissected after the end of stimulation and snap-frozen in liquid nitrogen. Animals 
were killed by intra-cardiac injection of Euthasol®, while still fully anaesthetised. Frozen 
muscles were stored at -80ºC until used for western blot, immunohistochemical and RT-
PCR analysis as described below.  
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Force traces collected during muscle stimulation were analysed using custom 
written software based on Matlab (v 7.5.0., The Mathworks Inc., MA, USA). Time to peak 
twitch force (TTP), half-relaxation time (HRT), maximum active twitch force (Ftw) and 
active maximum tetanic force (Fmax) (total force minus passive force) were determined. 
The same contraction parameters were determined for a group of non-transfected muscles 
(NTm; SOL/GM n=8). Values obtained for the two twitch values in each trace were 
averaged. 
 
Protein biochemistry 
Western blotting 
To analyse protein expression, frozen 25 µm thick cross-sections taken from the centre 
portion of the muscle were homogenised in ice-cold RIPA buffer (50mM TRIS-HCl (pH 
7.5), 150 mM NaCl, 1 mM EDTA, 1% v/v Nonidet P40 substitute, 0.25% w/v sodium 
deoxycholate) plus freshly added protease/phosphatase inhibitors: 1 mM NaF, 1 mM 
Na3VO4, 0.1 mM PMSF, 1 µg/ml leupeptin, 0.2 µg/ml pepstatin, 0.1 µg/ml aprotinin, all 
from Sigma-Aldrich, Dorset, UK) using a Polytron homogeniser (Kinematica, Luzern, 
Switzerland). Crude homogenates were aspirated 5-10 times through a 0.8 mm syringe 
needle, and stored at -80ºC until use for analysis. An aliquot of the aspirated homogenate 
was taken for determination of protein concentration with the bicinchoninic acid protein 
assay (Pierce, Rockford IL, USA). 
Protein levels of total CaMKII and phospho
Thr287
-CaMKII were analysed by 
western blotting followed by immunodetection. Homogenates were denatured by addition 
of SDS-PAGE buffer (final concentration: 50 mM TRIS-HCl (pH 6.8), 2% w/v SDS, 2% 
w/v bromophenol blue, 10% v/v glycerol, 2% β-mercaptoethanol) and five minutes heating 
at 95ºC. 20-40 µg of protein was separated by SDS-PAGE and transferred overnight onto a 
nitrocellulose membrane (GE Healthcare, Little Chalfont, UK). Membranes were stained 
with Ponceau S solution to confirm equal protein loading and transfer. The membrane was 
blocked in 5% skimmed milk in TRIS-buffered saline (pH 7.4) with 0.05% tween-20 
(TBS-T), followed by  incubation with a primary antibody for either pan-CaMKII (BD 
Bioscience #611292, dilution: 1/2500), phospho
Thr287
-CaMKII (Cell Signalling Technology 
#3361, dilution: 1/1000) or COXIV (Cell Signalling Technology #4850, dilution: 1/2000) 
for 2 hours. Antibody incubation solutions were 5% milk in TBS-T (for pan-CaMKII) or 
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5% bovine serum albumin (BSA) in TBS-T (for phospho
Thr287
-CaMKII and COXIV). 
Finally, membranes were incubated with species-specific horseradish peroxidase-
conjugated secondary antibodies (Millipore, Watford, UK). Membranes were washed in 
TBS-T for 4 x 5 minutes after both antibody incubations. Antibodies were detected with an 
enhanced chemiluminescence kit (Pierce, Rockford IL, USA). Light signals were captured 
with a ChemiDoc XRS system (Biorad, Hemel Hempstead, UK).  
Transfected muscle pairs from the same animal were run on the same blot. 
Measures were limited to animals whose CaMKII-transfected muscles showed increased 
expression of the exogenous CaMKII isoforms on a western blot. Protein bands were 
quantified with Quantity One version 4.6.8 (Biorad). For the analysis of COXIV protein, a 
reference muscle sample was run on every blot, and COXIV protein bands were 
standardised to the intensity of this sample. These values were subsequently expressed as 
relative to the mean of the empty-transfected muscles. 
 
In vitro CaMKII phosphorylation 
To detect endogenous and exogenous calcium/calmodulin-sensitive protein bands, CaMKII 
was phosphorylated in vitro by addition of a calcium/calmodulin mixture to protein 
extracts of non-transfected and transfected muscle as described previously (Fluck et al., 
2000b). Phosphorylated CaMKII was subjected to SDS-PAGE and immunoblotted as 
described. 
 
Immunofluorescence & confocal microscopy 
To investigate differences in protein expression at the single fibre level, 
immunofluorescence stains were performed on cryosections of transfected muscles. 
Sections (12 µm thickness) were cut on a cryostat and dried for 30 minutes on glass slides. 
Sections were then fixed with ice-cold acetone and blocked with 5% normal goat serum in 
phosphate buffered saline, pH 7.5 (PBS). CaMKII and COXIV or CaMKII and SERCA2 
were detected simultaneously using commercially available primary antibodies (dilutions: 
anti-CaMKII: 1/250; anti-COXIV: 1/250, anti-SERCA2 (Abcam #Ab3625 or Abcam 
#2A7-A1): 1/200) as described and species-specific Alexa 488/555 secondary antibodies 
(Invitrogen, Paisley, UK). Sections were washed with PBS for 4 x 5 minutes after both 
antibody incubations. To detect nuclei, sections were incubated for 10 minutes with TO-
48 
 
PRO-3 iodide (Invitrogen). Immunolabelled sections were embedded in fluorescence 
compatible mounting medium (DAKO, Ely, UK).  
Protein expression in transfected fibres was analysed on a TCS SP5 confocal 
microscope (Leica, Milton Keynes, UK). A 10x objective was used in combination with 4x 
optical zoom. The fluorescent labels were excited with an Argon laser at 488nm and HeNe 
lasers at 543 nm and 633 nm. The pinhole was set to match the thickness of the stained 
section and the focus plane was adjusted to maximise signal detection. Dyes were excited 
separately using a sequential scanning mode. Detected light spectra were set to maximise 
signal detection, but care was taken to prevent cross-excitation of dyes. Laser intensity was 
set to produce images with few under- or overexposed pixels, and low levels of non-
specific staining, as indicated by light emission from sections that had been labelled with 
the secondary antibodies only. 8-Bit images were captured at 2048 x 2048 pixels, using 
100 Hz scanning speed and 5 times line averaging.            
COXIV staining in CaMKII-transfected muscle fibres (identified based on CaMKII 
staining intensity by visual inspection) was quantified with ImageJ (rsbweb.nih.gov/ij/). 
Fibres were circumscribed manually and the average pixel intensity within the fibre was 
measured. An approximately equal number of non-transfected fibres in the same image 
was measured as well, and acted as the control group of fibres to which the transfected 
fibres were compared. 
 
RT-PCR  
RNA extraction from muscles and RT-PCR analysis were carried out as described 
elsewhere (van Wessel et al., 2010). Total RNA was extracted from frozen 25 µm sections 
of transfected muscles using the RiboPure kit (Applied Biosystems). RNA concentration 
and purity (260/280 nm ratio; mean: 2.06, range: 1.92-2.09) were determined using a 
spectrophotometer (Nanodrop Technologies, Wilmington, DE). Total RNA concentration 
in muscle tissue was expressed as RNA (ng) per weight of the analysed sample (mg). Five 
hundred nanogram of total RNA per muscle was reverse transcribed using the high 
capacity RNA-to-cDNA kit (Applied Biosystems) containing random primers in a 20 µl 
total reaction volume. Tubes were heated at 25 ºC for 5 min, followed by 42 ºC for 30 min. 
Finally, the tubes were heated to 85ºC for 5 min to stop the reaction and stored at -80 ºC 
until used in the PCR reaction.  
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For each PCR target, 5 µl of the RT reaction product was amplified in duplicate 
using Fast Sybr Green mastermix (Applied Biosystems). The following transcripts were 
targeted: 18S ribosomal RNA (18S rRNA), cytochrome-c oxidase subunit 1 (COXI), 
cytochrome-c oxidase 4 (COXIV), succinate dehydrogenase subunit b (SDHb), 
peroxisome proliferator-activated receptor gamma-coactivator 1 alpha (PGC-1α) and 
SERCA2a. PCR primers were designed using Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Primer sequences and Genbank 
accession numbers for the transcripts are shown in table 1. Amplification efficiency of the 
primers used was 92.7-102.0%, and melting curve analysis demonstrated specific 
amplification. The range of cycle threshold values was 13-25. For 18S rRNA, mean cycle 
threshold values were converted into relative concentrations by 2
-Ct
. For all other 
transcripts, 18S rRNA cycle threshold was subtracted from the mean cycle threshold value 
of the specific target to obtain ∆Ct and converted into relative concentrations by 2
-∆Ct
.      
 
Target mRNA PCR primer sequence 5’→ 3’ 
 
Genbank Accession nr. 
18S RNA Forward: CGAACGTCTGCCCTATCAACTT   EU 139318.1 
 Reverse: ACCCGTGGTCACCATGGTA     
COXI Forward: TGCCAGTATTAGCAGCAGGT X14848.1 
 Reverse:  GAATTGGGTCTCCACCTCCA  
COXIV (isoform 1) Forward: AGTCCAATTGTACCGCATCC NM 017202.1 
 Reverse:  ACTCATTGGTGCCCTTGTTC  
SDH (subunit b) Forward: CAGAGAAGGGATCTGTGGCT NM 001100539.1 
 Reverse:  TGTTGCCTCCGTTGATGTTC  
PGC-1α Forward: ATGAGAAGCGGGAGTCTGAA NM 031347.1 
 Reverse: GCGCTCTTCAATTGCTTTCT  
SERCA2a Forward: GGCCCGAAACTACCTGGAGCC 
Reverse: CAACGCACATGCACGCACCC 
NM 001110139.2 
  
 
Table 1: Primers sequences used for RT-PCR analysis of mRNA targets 
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Statistics   
Statistical analyses were carried out with SPSS16 (SPSS Inc, IL, USA). 
Immunofluorescence data from non-transfected fibres and CaMKII-transfected fibres in 
the same muscle were analysed with two-tailed paired t-tests. Western blot and RNA data 
from control- and CaMKII-transfected muscles were analysed with two-tailed Wilcoxon 
signed ranks tests. RNA data from non-transfected muscles and control-transfected 
muscles were analysed with a Mann-Whitney U-test. Effects of transfection on twitch and 
tetanic force parameters from non-transfected and control-transfected muscles were tested 
with a factorial ANOVA (muscle x transfection). Correlations between the increase in 
CaMKII protein level following transfection and changes in COXIV protein, all transcripts 
and force parameters were tested using Spearman’s rho. Non-parametric tests were run 
with exact significance. Significance level was set at p < 0.05. 
 
 
Results  
 
Endogenous and exogenous CaMKII expression and phosphorylation in skeletal 
muscle 
In vitro phosphorylation of CaMKII allowed the identification of four Ca
2+
/CaM-
dependent isoforms in rat skeletal muscle. Based on previously published results  (Bayer et 
al., 1998), we identified these bands as the βM, δA, δD and γB CaMKII isoforms (Fig. 1A). 
When CaMKII was overexpressed, we detected increased protein levels of α- and β-
CaMKII isoforms (which have molecular weights of 50 and 60 kDa, respectively) 
compared to control-transfected muscle (Fig. 1B). When homogenate of CaMKII-
transfected muscle was incubated with calcium and calmodulin, increased phosphorylation 
of CaMKII was detected (Fig. 1C). The overexpressed CaMKII was localized in the 
cytoplasm, but not in the myonuclei (Fig. 1D) 
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Figure 1: Expression of endogenous and exogenous CaMKII in rat skeletal muscle 
A: Endogenous total CaMKII (top panel) and phospho
Thr287
-CaMKII (bottom panel) of rat GM homogenate 
after incubation with EGTA (left) or Ca
2+
/Calmodulin (Ca
2+
/CaM). CaMKII isoforms were identified based 
on data from (Bayer et al., 1998). B: Representative western blot image demonstrating overexpression of the 
exogenous α (50kDa) and β (60kDa) CaMKII isoforms in m. gastrocnemius medialis (GM) and m. soleus 
(SOL). Note that skeletal muscle expresses endogenous isoforms with molecular weights of 72 and 57-60 
kDa (Bayer et al., 1998). CON: Control-transfected muscle; CaMKII: CaMKII-transfected muscle. C: Total 
CaMKII (top panel) and phospho
Thr287
-CaMKII (bottom panel) of α/β-CaMKII-transfected m. soleus 
homogenate after incubation with EGTA or Ca
2+
/CaM. D: Immunofluorescence image demonstrating non-
nuclear localisation of overexpressed CaMKII (red) in skeletal muscle fibres. Example CaMKII-transfected 
(Tf) and non-transfected fibres in the same muscle (NTf) are marked in the images by white letters. Nuclei 
are stained in blue. White arrows point to representative nuclei of transfected fibres. Green arrows point to 
central nucleus in transfected fibre, indicating regeneration. 
 
 
 
We assessed phosphorylation of endogenous and exogenous CaMKII after a two 
minute isometric contraction protocol. In contrast to a previous study (Rose et al., 2007a), 
we did not observe a consistent increase in phosphorylation of the endogenous CaMKII 
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isoforms after the two minute isometric protocol (GM: n=6; SOL: n=6; Fig. 2). However, 
in a number of stimulated muscles, we observed increased phospho-CaMKII with the 
molecular weight of exogenous β-CaMKII (see arrows in Fig. 2).  
 
 
 
 
 
Figure 2: Phosphorylation of exogenous CaMKII in rat skeletal muscle in situ 
Total CaMKII (top panel) and phospho
Thr287
-CaMKII in transfected m. gastrocnemius medialis (GM) and m. 
soleus (SOL). Endogenous and exogenous (bold) CaMKII isoforms are labelled. Red arrows indicate 
phosphoylated exogenous β-CaMKII in Stim-labelled lanes. Rest: non-stimulated muscle. Stim: muscle 
subjected to in situ stimulation (with stimulation frequency as indicated below the blots). 
 
 
Gene transfer-induced regeneration  
The presence of small fibres, fibres with central nuclei, and the accumulation of nuclei 
outside the fibres in transfected muscles indicated that these muscles were undergoing 
regeneration after gene electrotransfer (Fig. 1D). The gene transfer procedure also 
increased the concentration of total RNA in muscle tissue (non-transfected muscle: 284 
ng/mg tissue; control-transfected muscle: 708 ng/mg, p<0.01; Fig. 3). However, there was 
no difference in RNA concentration between control- and CaMKII-transfected intra-animal 
pairs (708 ng/mg vs. 735 ng/mg, p=0.81; Fig. 3A). 
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CaMKII is not sufficient to increase mitochondrial gene expression  
RT-PCR was used to investigate whether CaMKII overexpression increased transcript 
levels of components of the oxidative phosphorylation chain encoded by either nuclear 
(SDHb, COXIV) or mitochondrial (COXI) DNA, and the transcriptional co-factor PGC-1α 
which, when overexpressed, increases mitochondrial biogenesis (Wu et al., 1999). This 
analysis was limited to SOL, because of the higher transfection efficiency achieved in this 
muscle. Seven muscle samples were selected for analysis based on exogenous CaMKII 
expression level. 18S rRNA content did not differ between control- and CaMKII-
transfected muscles (Fig. 3B), and was used as an internal reference for the other 
transcripts. SDHb mRNA level was lower in CaMKII-overexpressing muscles (-26%, 
p=0.04), with no significant differences in transcript levels of COXIV, COXI or PGC-1α 
(Fig. 3C-F). No correlation was observed between the degree of CaMKII overexpression 
and the difference in transcript level for any of the transcripts.  
 
To test whether overexpression of  CaMKII was sufficient to increase COXIV protein 
expression in GM and SOL, cryosections of transfected muscles were co-stained for 
CaMKII and COXIV (Fig. 4A). COXIV staining intensity as measured by 
immunofluorescence in individual fibres of transfected muscles did not differ between 
CaMKII-overexpressing and non-transfected fibres of both GM (non-transfected: n=51, 
transfected: n=54; p=0.91) and SOL muscle (non-transfected: n=35, transfected: n=38; 
p=0.38) (Fig. 4A/B).   
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Figure 3: Effects of CaMKII transfection on mitochondrial gene transcript levels 
A: Concentration of total RNA in transfected and non-transfected muscles. B-F: relative concentrations of 
indicated transcripts in control and CaMKII-transfected m. soleus. Bars indicate mean data. Raw data are 
plotted as symbols and lines indicate intra-animal pairs. Same symbols indicate measurements on the same 
muscle. Significance of control- vs. CaMKII-transfected differences is indicated. NTm: Non-transfected 
muscle; Control: reporter only transfected; CaMKII: reporter + α/β-CaMKII transfected.    
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Figure 4: COXIV protein expression in CaMKII-transfected fibres  
A: Immunofluorescence images of transfected muscle fibres of m. gastrocnemius medialis (GM) and m. 
soleus (SOL) stained for different proteins as indicated. Black bar indicates 100 µm. B: Graphs displaying 
mean ± S.E.M. pixel intensities of transfected (Tf) and non-transfected (NTf) fibres in GM and SOL. 
Example Tf and NTf are marked in the images by white letters. Significance of NTf vs. Tf differences is 
indicated. Data are relative to NTf.  
 
 
CaMKII overexpression increases the speed of twitch contraction and relaxation  
CaMKII has been thought to affect calcium release from, and/or calcium re-uptake into, 
the SR. Because twitch contraction and relaxation speed during isometric contractions 
depend mainly on the properties of the SR (see for review Schiaffino, 2010), we 
investigated whether these parameters differed between control- and CaMKII-transfected 
muscles. Both TTP and HRT were higher in control-transfected muscle compared to non-
transfected muscle (TTP: +22%, p=0.05, main effect; HRT: +32%, p=0.03, main effect; 
Fig. 5). We observed a significant decrease in TTP and HRT in CaMKII-transfected 
muscles compared to control-transfected muscles (TTP: -16%, p=0.02, main effect; HRT: -
15%, p=0.04, main effect; Fig. 5).  
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Figure 5: Effects of CaMKII overexpression on twitch contraction/relaxation time 
A: m. soleus (SOL) time-to-peak twitch force (TTP); B: m. gastrocnemius medialis (GM) TTP; C: SOL 
twitch half relaxation time (HRT); D: GM twitch HRT. Bars indicate mean data. Raw data are plotted as 
black dots for non-transfected muscles and as symbols for transfected muscle pairs. Lines indicate intra-
animal pairs and symbols indicate measurements on the same muscle. NTm: Non-transfected muscles; 
Control: reporter only-transfected muscles; CaMKII: reporter + α/β-CaMKII-transfected muscles. a Main 
effect of gene  transfer on TTP (p<0.05); 
b
 Main effect of CaMKII overexpression in TTP (p<0.05); 
c
 Main 
effect of gene transfer on HRT (p<0.05); 
d
 Main effect of CaMKII overexpression on HRT (p<0.05). 
 
 
SERCA2 protein expression increases in CaMKII overexpressing m. soleus fibres 
We investigated whether the observed reduction in HRT might be due to increased 
expression of the SERCA2 isoform. Examples of immunofluorescence CaMKII/SERCA2 
co-stained m. soleus fibres are shown in figure 6A. SERCA2 staining intensity in CaMKII-
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overexpressing m. soleus fibres was significantly higher compared to that in non-
transfected fibres of the same muscle (non-transfected: n=221, transfected: n=276; 
p<0.001; Fig. 6B). Identical results were obtained when the staining was repeated with a 
different anti-SERCA2 antibody. 
 
 
 
Figure 6: CaMKII overexpression increases SERCA2 expression in m. soleus fibres 
A: Example immunofluorescence images of m. soleus fibres stained for different proteins as indicated above 
the image. Bar indicates 100 µm.  B: Graphs displaying mean ± S.E.M. pixel intensities of transfected (Tf) 
and non-transfected (NTf) fibres in GM and SOL. Example Tf and NTf fibres are marked in the images by 
white letters. Significance of NTf vs. Tf differences is indicated. Data are relative to NTf.  
 
 
 We used RT-PCR to investigate whether CaMKII overexpression increased SERCA2 
transcript levels. Primer sequences for primers targeting the SERCA2a isoform, which is 
the predominant SERCA isoform in normal rat m. soleus (Zador et al., 1996), are shown in 
table 1. We did not observe an increase in SERCA2a mRNA in CaMKII-transfected 
compared to control-transfected m. soleus (Fig. 7). Rather, a trend for a down-regulation 
was apparent.  
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Figure 7: Effect of CaMKII-overexpression on SERCA2a transcript level in m. soleus fibres. 
Graph displays the relative transcript concentration in control and CaMKII-transfected m. soleus. Bars 
indicate mean data. Raw data are plotted as symbols (the same as Fig. 4) and lines indicate intra-animal pairs. 
Same symbols indicate measurements on the same muscle. Significance of control- vs. CaMKII-transfected 
differences is indicated. 
 
 
CaMKII overexpression does not increase maximum force and fatigue resistance  
Gene electro-transfer caused a decrease in maximal tetanic force (p<0.001, main effect), 
which was larger in SOL (-49%) than in GM (-14%) (Fig.8). Maximum twitch force was 
also reduced (p=0.03, main effect), but this reduction was of a lower magnitude compared 
to the reduction in maximal tetanic force (SOL: -18%; GM: -7%) (Fig.8). Both maximum 
tetanic and maximum twitch force did not differ between control- and CaMKII-transfected 
muscles. Finally, we observed no difference in fatigue resistance between control- and 
CaMKII-transfected GM during 50 repeated tetanic contractions (Fig. 9). 
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Figure 8: Maximum twitch and tetanic force of transfected and non-transfected muscles  
Top left: m. soleus (SOL) twitch force (Ftwitch); Top right: m. gastrocnemius medialis (GM) twitch force; 
Bottom left: SOL tetanic force (Fmax); Bottom right: GM tetanic force. Bars indicate mean data. Raw data are 
plotted as black dots for non-transfected muscles and as symbols for transfected muscle pairs. Lines indicate 
intra-animal pairs and symbols indicate measurements on the same animal. NTm: Non-transfected muscles; 
Control: reporter only-transfected muscles; CaMKII: reporter + α/β-CaMKII-transfected muscles. a Main 
effect of gene  transfer on Ftwitch (p<0.05); 
b
 Main effect of gene transfer on Fmax  (p<0.001). 
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Figure 9: Effects of CaMKII overexpression on force reduction during repeated maximal tetanic 
contractions of GM 
Graph displays tetanic force of m. gastrocnemius medialis (GM) during a contraction protocol consisting of 
50 repeated tetanic contractions. Maximal tetanic force (mean ± S.E.M.) of every fifth contraction is shown. 
NTm: Non-transfected muscles; Control: reporter only-transfected muscles; CaMKII: reporter + α/β-
CaMKII-transfected muscles.  
 
 
Discussion 
 
This is the first study that investigates whether manipulation of CaMKII expression affects 
skeletal muscle phenotype in vivo. In contrast to our hypothesis, we did not observe an 
increase in expression of genes related to mitochondrial biogenesis. However, twitch 
contraction and relaxation times were reduced in CaMKII-transfected muscles while 
SERCA2 protein levels in CaMKII-transfected muscle fibres were increased. Our results 
suggest the involvement of CaMKII in the regulation of the contraction-related phenotype, 
rather than mitochondrial biogenesis. 
 
Technical considerations  
Muscle damage and subsequent regeneration are inherent to gene electro-transfer, and this 
enhances the plasticity of the muscle. In myotoxin-induced muscle regeneration 
mitochondrial enzyme expression is decreased, and recovers from day 3 onwards (Duguez 
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et al., 2002). The increase in total RNA concentration in control-transfected muscles 
compared to non-transfected muscles in the present investigation (Fig. 3) was at least in 
part due to an increase in 18S rRNA (relative 18S rRNA levels, corrected for RNA 
concentration: NTm: 1.00±0.13; Control-transfected: 3.19±0.62; p<0.01), suggesting a 
higher ribosomal content and translational capacity in these muscles. Therefore, we 
propose this model is sensitised to stimuli that affect the muscle phenotype. 
The influence of the gene electro-transfer procedure per se does not affect the 
results of the comparison between transfected and non-transfected fibres, as these were 
located in the same region of the muscle (Fig. 4A & 6A), and both groups consisted of 
relatively small, regenerating fibres which were size-matched between the groups and 
displayed central nuclei.  
Increasing total protein level of native CaMKII in skeletal muscle results in 
potentially higher CaMKII activity which is still amenable to physiological regulation. In 
cardiac myocytes, overexpressing native CaMKII has effects on both functional 
characteristics and the expression of genes involved in excitation-contraction coupling and 
cardiac hypertrophy (Ramirez et al., 1997, Ronkainen et al., 2011). Our results suggest that 
exogenous CaMKII can be activated in skeletal muscle during muscle recruitment in vivo 
(Fig. 2). It is possible that increasing the physical activity of the rats in the period after the 
transfection procedure would have enhanced the effects of the overexpressed wild-type 
CaMKII because of increased recruitment of GM and SOL. It has been estimated that 
motor units in the soleus muscles of caged, but freely moving rats are active for 25-30% of 
a 24- hour period (Hennig and Lomo, 1985). Furthermore, rat SOL is recruited during 
postural and slow running activity (Gorassini et al., 2000). Therefore, we expected 
transfected fibres in this muscle to be frequently recruited. GM has been shown to be 
moderately activated during postural and slow running tasks and to be increasingly 
recruited during running at higher speeds (Gorassini et al., 2000). It is therefore possible 
that the exogenous CaMKII in transfected GM fibres was not sufficiently activated during 
normal cage activity for CaMKII activity-dependent effects on mitochondrial protein 
expression to manifest.  
 
CaMKII overexpression affects twitch contraction and relaxation speed  
Twitch contraction and relaxation times of CaMKII-overexpressing muscles were reduced 
compared to control-transfected muscles (Fig.5). This is consistent with CaMKII-
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dependent phosphorylation-induced increases in SERCA2 and RyR activities in vitro 
(Hawkins et al., 1994, Xu and Narayanan, 1999, Dulhunty et al., 2001), and with the 
finding that CaMKII inhibition reduced calcium release in single mouse muscle fibres 
(Tavi et al., 2003). CaMKII is targeted to the SR by binding to membrane-anchoring 
protein α-KAP, an α-CaMKII splice variant (Bayer et al., 1998). In skeletal muscle fibres, 
overexpressed α-KAP localises mostly to the longitudinal SR (Nori et al., 2003), where the 
sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCA) is situated. Furthermore, CaMKII is 
targeted to the junctional SR (Leddy et al., 1993), Therefore, CaMKII possibly has access 
to SERCA and RyR and could increase their activities through phosphorylation. However, 
GM expresses mainly the SERCA1 isoform that cannot be phosphorylated by CaMKII 
(Hawkins et al., 1994), and inhibitory effects of CaMKII on RyR activity have also been 
reported (Wang and Best, 1992). Therefore, it is unclear if CaMKII-dependent 
phosphorylation of SERCA and RyR played a role in decreasing twitch contraction and 
relaxation times in our study.  
Because the contraction experiments were carried out seven days after transfection, 
it is possible that structural adaptations occurred that decreased TTP and HRT. As 
mentioned, transfected fibres appear in a regenerating region of the muscle. If we assume 
that the observed increases in relaxation/contraction times in control-transfected muscles 
compared to those in non-transfected muscles are due to changes in muscle properties in 
this region, it becomes apparent that most of the effect of the gene transfer procedure is 
reversed or mitigated in the CaMKII overexpressing muscles (Fig. 5). Such adaptations 
might include increased densities of the RyR and SERCA on the SR membrane. Indeed, 
our data suggested that SERCA2 protein expression was increased in CaMKII-transfected 
m. soleus fibres (Fig. 6), a process which possibly contributed to the observed decrease in 
relaxation time.  
We observed no significant increase in maximal force production (Fig. 8). This 
might be explained by specific effects of the electroporation-induced damage on muscle 
force characteristics. The gene transfer procedure alone reduced maximal twitch force, but 
maximal tetanic force was more strongly reduced (Fig. 8). Specific force was likely also 
decreased in electroporated muscles. A decreased specific force and an increased ratio of 
twitch force to tetanic force in regenerating rat m. soleus have been shown to be associated 
with the expression of developmental isoforms of EC-coupling proteins  (Esposito et al., 
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2007). Therefore, it may be that any increase in Fmax was masked by negative effects of 
muscle damage on EC-coupling.  
 
CaMKII overexpression reduces, rather than increases, mitochondrial gene 
expression  
In contrast to our expectations, we observed no increase in mitochondrial protein COXIV 
(Fig. 4) and fatigue resistance (Fig. 9) in CaMKII-overexpressing muscles compared to 
control-transfected muscles. To the best of our knowledge, this is the first study 
investigating whether CaMKII increases the expression of a mitochondrial protein in any 
tissue type. 
Constitutively active CaMKIV increases mitochondrial biogenesis when overexpressed 
from an embryonic stage onward (Wu et al., 2002), but this CaMK is not endogenously 
expressed in skeletal muscle (Akimoto et al., 2004, Rose et al., 2006) and CaMKIV knock-
out mice do not display altered muscle adaptation in response to training (Akimoto et al., 
2004). Whether CaMKIV would have a similar function in skeletal muscle compared to 
CaMKII is questionable, since the two proteins have different substrate specificity and 
intracellular localisation (Sun et al., 1996, Srinivasan et al., 1994, Sun et al., 1994).  
The absence of a difference in fatigue resistance between control- and CaMKII-
transfected muscles might be due to the muscle oxidative capacity not being the limiting 
factor in the synthesis of ATP under full anaesthesia. Our repeated contraction protocol 
almost certainly required a significant contribution of oxidative metabolism to ATP 
synthesis (Westra et al., 1988), but if blood flow to the working muscle was insufficient to 
meet the increased demand for oxygen, differences in oxidative capacity of the muscles 
may be masked. 
Our finding that CaMKII overexpression did not increase COXIV protein 
expression was confirmed at the mRNA level. Furthermore, transcript levels of other key 
genes involved in mitochondrial biogenesis were either not significantly changed or 
decreased (Fig. 3). This absence of increased gene expression is in accordance with 
experiments demonstrating that acute inhibition of CaMKII in vivo in mice did not affect 
GLUT4 protein expression (Witczak et al., 2010). The results demonstrate that CaMKII is 
not sufficient to increase mitochondrial gene expression, but do not rule out the possibility 
that it is required for the response to exercise. The idea that CaMKII signalling acts in 
conjunction with other signalling pathways is supported by the observation that the activity 
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of a GLUT4-enhancer in mouse tibialis anterior muscle is only decreased when CaMKII is 
co-inhibited with either AMPK or calcineurin (Murgia et al., 2009). 
 
Conclusion 
Our results support a role for CaMKII in the regulation of muscle contraction and SERCA2 
expression, but not in increasing mitochondrial biogenesis. The fact that these observations 
were made after an in vivo intervention in whole muscle is significant in the context of 
current literature on CaMKII function in ex vivo or in vitro systems.          
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Chapter 4: Effect of CaMKII overexpression on skeletal alpha-actin 
transcription in rat skeletal muscle 
 
Abstract 
 
The effect of CaMKII overexpression on the transcriptional activity of one of its potential 
target genes, skeletal alpha-actin (SKAA) was investigated. The luciferase gene controlled 
by a SKAA promoter fragment was transfected into m. soleus (SOL) and m. gastrocnemius 
(GM) of both hindlimbs of three month-old female wistar rats (n=13). CaMKII was 
overexpressed in SOL and GM of the right leg only. Luciferase activity measured in 
protein extracts of the transfected muscles seven days after transfection was significantly 
lower in SOL (p=0.02) and GM (p=0.04) of the CaMKII-transfected leg. SKAA mRNA 
level tended to be lower in the CaMKII transfected leg, but this was not significant. We 
conclude that CaMKII overexpression has a negative effect on SKAA gene transcription, 
but the mechanisms underlying this effect require further investigation.   
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Introduction 
 
Repeated high mechanical loading of skeletal muscle typically results in hypertrophy, 
which requires an increased net synthesis of contractile proteins actin and myosin. 
Overloading of chicken muscle by attaching weights to the wing increases the activity of 
the skeletal alpha-actin (SKAA) gene promoter in the m. anterior latissimus dorsi (Carson 
et al., 1995). The serum response element SRE1 in the promoter of the SKAA gene, which 
is bound by the serum response factor (SRF), is necessary and sufficient to induce the 
loading-dependent increase in SKAA promoter activity (Carson et al., 1996). However, the 
upstream mechanisms regulating this promoter activity are not completely understood.  
Calcium/calmodulin-dependent protein kinase II (CaMKII) is a candidate to 
transduce increased muscle recruitment into changes in SKAA expression. 
Ca
2+
/calmodulin-independent CaMKII activity and SRF phosphorylation are both 
increased after chronic overload of chicken muscle and knee extension-endurance training 
in humans (Fluck et al., 2000b, Rose et al., 2007b). Phosphorylation of SRF at Ser103 
increases its binding to serum response elements (Rivera et al., 1993), while 
phosphorylation at Thr160 inhibits this binding (Wheaton and Riabowol, 2004). CaMKII 
can phosphorylate SRF at both Ser103 and Thr160 (Fluck et al., 2000a). Because there is a 
positive association between CaMKII activity and SRF binding to the SKAA promoter 
after high muscle loading, we hypothesised that CaMKII overexpression would increase 
the activity of the SKAA promoter, and SKAA mRNA level in rat skeletal muscle. To test 
this hypothesis, we introduced a SKAA-promoter construct containing three functional 
SRE elements into muscles of the right and left hind limbs of rats. CaMKII was 
overexpressed in the right leg only. To test whether CaMKII-dependent regulation depends 
on fibre type, we used fast-twitch m. gastrocnemius and slow-twitch m. soleus for these 
experiments. 
 
Methods  
 
Ethical approval 
A total of 13 female Wistar rats were used for the experiments described here. In situ 
contraction protocols and the majority of the transfections were carried out at the MOVE 
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Research Institute Amsterdam, VU University Amsterdam, The Netherlands and approved 
by the local Animal Experiments Committee. Two transfection experiments were carried 
out at the Department of Cardiovascular Surgery, University Hospital Bern, Switzerland 
and approved by the animal protection commission of the Canton of Berne, Switzerland. 
 
Somatic overexpression of CaMKII and a skeletal alpha-actin reporter gene  
Plasmids 
PCDNA3 plasmids encoding full-length cDNA for CaMKIIα and CaMKIIβ were a gift 
from Dr. M Neal Waxham (University of Texas, Houston, USA). PGL2 plasmid encoding 
full-length luciferase under control of 424basepairs upstream of the transcription start site 
of the chicken SKAA gene (SKAA-424) (Marsh et al., 1998) was a gift from Dr. Frank W. 
Booth (University of Missouri, Columbia, USA).  This promoter construct contains three 
serum response elements, two Sp1 binding elements, one E Box, one MCAT and one 
TATA Box as described previously (Carson et al., 1995). These regulatory elements are 
conserved across species (Ordahl and Cooper, 1983). 
 
Transfection  
Three month-old female Wistar rats (n=13; Harlan Laboratories and Charles River; body 
weight: 191-230 grams) were used to overexpress CaMKII in m. gastrocnemius medialis 
(GM) and m. soleus (SOL). The animals were anaesthetised with 2-4% isoflurane through 
inhalation. Hind limbs were shaved, and skin was disinfected with 70% ethanol. An 
incision was made into the skin and fascia between GM and m. tibialis anterior. SOL was 
subsequently exposed and liberated, after which four injections of plasmid mixture with a 
total volume of 90 µl were administered intramuscularly using a 29-gauge insulin syringe. 
GM was administered four injections over the length of the muscle with a total volume of 
180 µl. A mix of expression plasmid for full-length CaMKIIα (pCDNA3-CaMKIIα; 0.22 
µg/µl) and full-length CaMKIIβ (pCDNA3-CaMKIIβ; 0.22 µg/µl) in Tris-Borate-EDTA 
buffer was injected into muscles of the right leg together with the SKAA-424 reporter 
plasmid (0.55 µg/µl). Muscles of the left leg were injected with the reporter plasmid only 
(1 µg/µl). Right and left transfected muscles will henceforth be referred to as ‘CaMKII-
transfected’ and ‘control-transfected’, respectively. DNA injection was followed by 
electroporation with a GET42 electropulser (E.I.P. Electronique et Informatique du Pilat, 
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Jonzieux, France). Needle electrodes were placed along SOL or into GM and pulse 
protocols were applied as described previously (Durieux et al., 2009). 
After electroporation, the skin wound was closed with sutures, and the animal was 
allowed to recover from anaesthesia. Animals were kept in cages individually afterwards, 
where they resumed normal activity within hours after surgery. After seven days, animals 
were anaesthetised with 12.5% urethane to measure muscle contractile parameters as 
described in chapter 3.Transfected muscles were harvested from both legs of anaesthetised 
rats and snap-frozen in liquid nitrogen. The rats were killed afterwards by an intra-cardiac 
injection of Euthasol® while under full anaesthesia.  
 
Luciferase reporter assay 
Frozen muscle samples were homogenised in RIPA buffer as described for western blots in 
chapter 3. Homogenates were centrifuged at 10000 RPM for 10 minutes at 4ºC. The 
supernatant was collected and stored at -80ºC. Protein concentration was determined with 
the BCA method (Pierce, Rockford IL, USA). To assay luciferase activity, 20 µg of protein 
was added to a reaction mix (tricine (2 mM, pH 7.8); MgCl2 (5 mM), EDTA (2 mM), 
dithiothreitol (33.3 mM), ATP (0.25 mM), Coenzyme A (0.27 mM and firefly luciferin 
(Promega; 0.47mM)) in a white 96-well plate (Eppendorf, Stevenage, UK) at a final 
volume of 100 µl. Light production was measured with a Hidex Chameleon Plate reader 
(Hidex; Turku, Finland) for 10 minutes, and the maximum emission ( photon counts per 
second) was taken as a measure of luciferase activity. Measurements were performed in 
triplicates and intra-animal muscle pairs were always assayed simultaneously. A reference 
protein sample from a luciferase-expressing muscle was always run alongside the 
experimental samples to check the reproducibility of the luciferase measurements.  
 
RNA isolation and RT-PCR 
RNA extraction and RT-PCR analysis were carried out as described elsewhere (van Wessel 
et al., 2010). Total RNA was extracted from frozen 25 µm sections of transfected muscles 
using the RiboPure kit (Applied Biosystems). RNA concentration and purity (260/280 nm 
ratio; mean: 2.06, range: 1.92-2.09) were determined using a spectrophotometer (Nanodrop 
Technologies, Wilmington, DE). Five hundred nanogram of total RNA per muscle was 
reverse transcribed using the high capacity RNA-to-cDNA kit (Applied Biosystems) 
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containing random primers in a 20 µl total reaction volume. Tubes were heated at 25ºC for 
5 min, followed by 42ºC for 30 min. Finally, the tubes were heated to 85ºC for 5 min to 
stop the reaction and stored at -80ºC until used in the PCR reaction.  
For each PCR target, 5 µl of the RT reaction product was amplified in duplicate 
using Fast Sybr Green mastermix (Applied Biosystems). 18S ribosomal RNA (18S rRNA) 
and skeletal alpha-actin (SKAA) mRNA were amplified. Primer sequences are shown in 
table 1. Amplification efficiency of the primers used was 94.5-102.0%, and melting curve 
analysis demonstrated specific amplification. The range of cycle threshold values was 13-
25. For 18S rRNA, mean cycle threshold values were converted into relative 
concentrations by 2
-Ct
. To quantify the SKAA transcript, 18S rRNA cycle threshold was 
subtracted from the mean cycle threshold value of the specific target to obtain ∆Ct and 
converted into a relative concentration by 2
-∆Ct
.      
 
Statistics 
The differences in luciferase activity and SKAA transcript level between control- and 
CaMKII-transfected muscle pairs were tested with a two-sided wilcoxon signed-ranks test. 
Significance was accepted at p<0.05. 
 
 
Target mRNA PCR primer sequence 5’→ 3’ 
 
GenBank accession nr 
18S RNA Forward: CGAACGTCTGCCCTATCAACTT   EU 139318.1 
 Reverse: ACCCGTGGTCACCATGGTA     
SKAA Forward: CGACATCGACATCAGGAAGGA  NM 019212.2 
 Reverse: GGTAGTGCCCCCTGACATGA  
 
Table 1: Primers sequences used for RT-PCR analysis of mRNA targets 
 
 
Results 
 
Luciferase activity was significantly lower in CaMKII-transfected SOL and GM (Figure 
1A), indicating that SKAA promoter activity had been lower in these muscles. In 
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accordance with the lower promoter activity, SKAA transcript levels tended to be lower in 
CaMKII-transfected m. soleus (Figure 1B), but this was not significant.  
 
 
 
Figure 1: Effects of CaMKII overexpression on SKAA promoter activity and mRNA level 
A). Luciferase activity (in photon counts per second, CPS) in 20 µg of protein homogenate of 
CaMKII+SKAA-424-luciferase-transfected muscles (CaMKII) and SKAA-424-luciferase-transfected only 
(Control) muscles. SOL: m. soleus. GM: m.gastrocnemius. B). SKAA mRNA level normalized to 18S rRNA 
in CaMKII+SKAA-424-luciferase-transfected (CaMKII) and SKAA-424-luciferase-transfected only 
(Control) m. soleus. Dots indicate individual measurements, and dashed lines connect measurements on intra-
animal muscle pairs. Statistical significance of the comparison between Control- and CaMKII-transfected 
muscles is indicated above the bars. SKAA: skeletal alpha-actin.      
 
 
Discussion 
 
 In contrast to our expectations, SKAA promoter activity in CaMKII-transfected muscles 
was decreased rather than increased compared to control-transfected muscles, and SKAA 
mRNA tended to be decreased in CaMKII-transfected muscles. 
What might be the explanation for our observation that SKAA-424 promoter activity is 
decreased with CaMKII overexpression, regardless of fibre type? CaMKII can 
phosphorylate SRF at two sites at least, Ser103 and Thr160 (Fluck et al., 2000a). 
Phosphorylation at Ser103 increases its binding to the serum response element (Rivera et 
al., 1993), while phosphorylation of SRF at Thr160 inhibits binding to the SRE (Wheaton 
and Riabowol, 2004). Therefore, a possible explanation for our results is that CaMKII 
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overexpression increased SRF phosphorylation at Thr160, which reduced SRF binding to 
the SRE and the expression of the SKAA -424 promoter-dependent luciferase activity. 
 
Is it possible that CaMKII activates another pathway with inhibitory effects on SKAA gene 
expression? CaMKII can affect the transcription of multiple genes through phosphorylation 
of histone deacetylase 4 (HDAC4) (Backs et al., 2006). However, phosphorylation of 
HDAC4 releases HDAC4-mediated inhibition of SRF-activated transcription of a SKAA-
reporter gene (Davis et al., 2003), and would thus be expected to increase, rather than 
decrease, SKAA promoter activity and transcription. CaMKII also phosphorylates H1 
histone in vitro (Woodgett et al., 1983), but phosphorylated H1 histone is also associated 
with increased, rather than decreased transcriptional activity (Zheng et al., 2010). In 
conclusion, no pathway is known through which CaMKII can inhibit SKAA gene 
expression. 
 
If CaMKII only activates pathways that stimulate gene expression, as discussed above, 
perhaps overexpression of CaMKII somehow inhibited this positive effect on gene 
transcription. The intracellular localisation of overexpressed CaMKII has been shown to be 
important for the CaMKII-dependent effect on gene transcription in other cell types. In 
ventricular cardiomyocytes, nuclear-targeted CaMKII was required to activate 
transcription of the atrial natriuretic factor (ANF) (Ramirez et al., 1997). However, nuclear 
CaMKII isoforms were depleted from the nucleus by overexpression of cytosolic isoforms 
which do not contain a nuclear localisation sequence (NLS), and this prevented ANF 
transcription. This phenomenon has also been observed in fibroblasts where nuclear or 
cytosolic targeting depended on the expression ratio of CaMKII isoforms containing an 
NLS and CaMKII isoforms that do not (Srinivasan et al., 1994). The α/β-CaMKII isoforms 
used in the present study do not contain a NLS and were localised to the cytoplasm and 
excluded from the nucleus of transfected fibres (Chapter 3). In nuclear extracts of non-
transfected chicken skeletal muscle, CaMKII activity has been measured  (Fluck et al., 
2000a) which raises the possibility that α/β-CaMKII overexpression had an inhibitive 
effect on gene expression similar to that observed in cardiomyocytes. However, the 
CaMKII isoforms thought to be expressed in skeletal muscle do not contain a nuclear 
localisation sequence (Bayer et al., 1998). This suggests that nuclear targeting of these 
isoforms might depend on the anchoring protein α-KAP (Nori et al., 2003), and that factors 
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other than the ratio of nuclear and cytosolic CaMKII isoforms expressed are important in 
determining whether CaMKII is localised to the nucleus. In conclusion, it is unclear 
whether CaMKII can be depleted from the nuclei of skeletal muscle fibres by 
overexpression of cytosolic CaMKII isoforms.  
 
We conclude that CaMKII affects the activity of the SKAA promoter in skeletal muscle, 
but the precise mechanisms underlying this regulation are yet unclear. Future research 
should identify whether manipulation of CaMKII affects SRF phosphorylation, and which 
promoter elements are involved in the CaMKII-dependent regulation in skeletal muscle in 
vivo.  
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Chapter 5: Computational modelling of CaMKII activity and its 
effects on calcium dynamics in sarcomeres 
 
Abstract 
 
Calcium/calmodulin-dependent protein kinase II (CaMKII) has been demonstrated to 
modulate calcium release from the sarcoplasmic reticulum and phosphorylate the 
sarco/endoplasmic reticulum Ca
2+
-ATPase in vitro. CaMKII overexpression in skeletal 
muscle in vivo increased twitch contraction and relaxation speed (chapter 3). However, it is 
unclear if CaMKII-dependent modification of RyR and SERCA activity is sufficient to 
explain the increase twitch speed. In addition, it is unclear if CaMKII activation is similar 
throughout the subsarcomeric space or if activation is higher near the calcium release sites. 
To address these questions, we used a mathematical model of spatiotemporal sarcomeric 
[Ca
2+
] dynamics coupled to a biochemical model of CaMKII activation. Modelling results 
were compared to experimental results. The model predicted substantial spatial gradients in 
CaMKII activity in sarcomeres of fast- and slow-twitch muscle fibres during single and 
repeated RyR openings. Increasing the CaMKII concentration in the model did not produce 
faster twitch speeds, which could be explained by minimal CaMKII activation during 
twitch contraction. Experimental overexpression of CaMKII increased SERCA2 
expression in rat m. soleus muscle fibres and this could at least partially explain the 
observed decrease in twitch relaxation time (chapter 3). We conclude that not an increased 
CaMKII-dependent SERCA activity, but increased SERCA protein level underlies the 
increase in twitch relaxation speed after CaMKII overexpression.  
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Introduction 
 
In skeletal muscle, calcium/calmodulin-dependent protein kinase II (CaMKII) is presumed 
to regulate calcium release from, and re-uptake into, the sarcoplasmic reticulum (SR) of 
skeletal muscle fibres through modification of the ryanodine receptor (RyR) and the 
sarco/endoplasmic reticulum Ca
2+
-ATPase (SERCA), respectively. Acute pharmacological 
inhibition of CaMKII has an inhibitory effect on calcium release during tetanic 
contractions of single fast-twitch mouse fibres (Tavi et al., 2003), suggesting that CaMKII 
stimulates opening of the RyR. Furthermore, SERCA phosphorylation by CaMKII 
increases maximal activity of the slow-twitch SERCA isoform in isolated SR membranes 
(Hawkins et al., 1994, Xu and Narayanan, 1999). In addition, CaMKII increases SERCA 
activity by phosphorylating regulatory proteins sarcolipin (Bhupathy et al., 2009, Tupling 
et al., 2011) and phospholamban (MacLennan and Kranias, 2003). Finally, CaMKII 
overexpression in rat skeletal muscle in vivo decreased twitch contraction and relaxation 
times (chapter 3). These findings support the idea that the speed of calcium release and re-
uptake in muscle fibres can be altered via modification of RyR and SERCA by CaMKII.  
 These targets, however, have a specific spatial distribution within a sarcomere. RyR 
is located at the terminal cisternae of the SR (Inui et al., 1987), whereas SERCA is located 
on the longitudinal SR (Jorgensen et al., 1982). It has been demonstrated in mouse m. 
flexor digitorum brevis fibres that the increase in cytoplasmic [Ca
2+
] after a single 
depolarisation depends on the location within a sarcomere, with the largest change 
occurring near the calcium release site, and the smallest changes near the m-line (Gomez et 
al., 2006). As the increase in cytoplasmic [Ca
2+
] is probably essential for contraction-
induced CaMKII activation, there may also be a substantial gradient in CaMKII activity in 
sarcomeres. This raises the question whether CaMKII can affect SERCA, a target which is 
not in the immediate vicinity of the calcium release site, in skeletal muscle fibres.  
 We investigated whether, upon calcium release from the SR, CaMKII is activated 
to a greater extend when it’s located in the vicinity of the RyR and whether increasing 
sarcomeric CaMKII concentration decreases the speed of calcium release from and re-
uptake into the SR. The complexity of the required measures means that an in vivo 
approach is unfeasible. We therefore coupled computational models of spatiotemporal 
sarcomeric [Ca
2+
] dynamics in slow-twitch and fast-twitch fibres to models of CaMKII 
activation and RyR/SERCA modulation.    
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Methods 
 
Description of spatiotemporal calcium dynamics model 
A computational model describing spatiotemporal [Ca
2+
] dynamics in a half sarcomere of a 
fast-twitch mouse muscle (Groenendaal et al., 2008) was extended with a detailed 
biochemical model describing CaMKII activation (Saucerman 2008). Both models consist 
of coupled differential equations and contain no stochastic elements. The code for the 
sarcomeric model was kindly provided by Dr. Willemijn Groenendaal (Eindhoven 
University of Technology, The Netherlands). The sarcomeric model describes a cylinder 
consisting of four radial layers, of which the inner three form the myoplasm and the outer 
layer forms the sarcoplasmic reticulum (SR). Longitudinally, the layers are divided into six 
parts of equal volume, to form 18 myoplasmic elements and six SR elements (Fig. 1A). 
The number of elements in the model was limited to 24 to prevent excessive computational 
times and remain within computer memory limits. The elements include buffering of 
calcium by troponin-C, parvalbumin (in fast-twitch muscle) and ATP in the myoplasm and 
calsequestrin in the SR. In the model, calcium is able to diffuse within the myoplasm and 
the SR, and is transported between these two compartments through the RyR and SERCA, 
which have distinct locations on the modelled SR (Fig. 1A). 
 Sarcomeres of both fast-twitch (FT) and slow twitch (ST) muscle fibres were 
modelled. Clear structural and biochemical differences exist between these fibre types and 
these were implemented as previously described (Groenendaal, 2011). In comparison with 
the FT model, the ST model has:  
 no parvalbumin 
 a 50% lower SR volume, relative to the volume of the myoplasm. 
 2.4 fold lower maximal RyR activity 
 3 fold lower maximal SERCA activity 
 fewer Ca2+ binding sites on troponin 
 1.5 fold higher resting myoplasmic [Ca2+] 
 lower ATP concentration 
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Extension of calcium model with CaMKII reaction scheme 
To each myoplasmic element in the model, we added a CaMKII reaction scheme 
describing Ca
2+
 binding to calmodulin (CaM) (Fig. 1B) and subsequent binding of Ca
2+
-
CaM to CaMKII (Saucerman and Bers, 2008). Six different fractions of CaMKII exist in 
the model (Fig. 1C): Pi (inactive), Pb2 (Ca2CaM-bound), Pb (Ca4CaM-bound), Pt2 
(Ca2CaM-bound and phosphorylated at Thr287), Pt (Ca4CaM-bound and phoshorylated at 
Thr287) and Pa (unbound and phosphorylated at Thr287). Of these fractions, Pb, Pt2, Pt 
and Pa were assumed to have 100% activity. In the model, CaMKII phosphorylation is 
reversed by protein phosphatase 1 (PP1) (Fig. 1C). 
Some modifications were made to the CaMKII reaction scheme described by 
Saucerman & Bers. We removed CaM-buffering from the model and modelled only free 
CaM. Furthermore, we used different reaction kinetic parameter values for a number of 
reactions, which we found to be more in agreement with available literature (Appendix). 
The absolute concentrations of Pi, Pb, Pb2, Pt, Pt2 and Pa, instead of concentrations 
normalized to total CaMKII concentration, were used to calculate reaction rates. This 
allowed us to investigate the effect of changes in CaMKII concentration on calcium 
dynamics. Isoform-specific parameters for the β-CaMKII isoform were used to describe 
CaM-affinity for CaMKII (Gaertner et al., 2004).  
 CaMKII-dependent modification of SERCA activity was implemented in the ST 
model as previously described for modelled cardiomyocytes (Koivumaki et al., 2009), 
while in the FT model regulation of SERCA activity was absent (Hawkins et al., 1994). In 
both the FT and the ST model, the RyR parameter 'Power1' was made dependent on the 
level of active CaMKII to prolong opening of the RyR in a similar way to that used for a 
model of cardiomyocytes (Hund and Rudy, 2004) (see Appendix). The values of KmMax 
and DPowermax, which describe how strongly CaMKII activity affects the activity of RyR 
and SERCA (Appendix), were set so that the model could reproduce the CaMKII 
inhibition-induced decrease in calcium release during a 70Hz contraction, which has been 
previously demonstrated experimentally in single mouse fast-twitch muscle fibres (Tavi et 
al., 2003). The experiment by Tavi et al, which involved pharmacological inhibition of 
CaMKII, was modelled by removing the CaMKII-dependent modifications of RyR from 
our FT model. Although it was not explicitly demonstrated by Tavi et al. (2003), it was 
assumed that the pharmacological inhibition of CaMKII was absolute and specific. The FT 
77 
 
values of KmMax and DPowermax were subsequently incorporated into the ST model as 
well, as there is no similar experimental evidence available for this muscle type.    
 
 
Figure 1: Schematized calcium model and CaM-CaMKII reaction schemes. 
A: Simplified visualisation of the different spatial elements in the computational model of calcium dynamics 
in a half-sarcomere, adapted from Groenendaal et al. (2008). The model is bordered by a z-line on one side 
and an m-line on the other side. The grey elements (top row) make up the SR and the white elements (bottom 
tree rows) make up the myoplasm. Note that the actual model is a cylinder, and the elements are actually 
rings, with the lower border of the bottom elements as their centre. B: Reaction scheme for sequential 
binding of calcium to the C-terminal and then the N-terminal EF-hand of calmodulin. C: Reaction scheme for 
binding of calcium and calmodulin to CaMKII, and conversion of the CaMKII fractions to a phosphorylated 
state. pThr287 indicates that CaMKII is phosphorylated at threonine287. Phosphorylation of CaMKII at 
threonine 287 in the model is reversed by the action of protein phosphatase 1 (PP1). CaMKII fractions in 
bold have 100% activity and the CaMKII fractions in normal font have no activity. Both CaM and CaMKII 
reaction schemes were adapted from Saucerman & Bers (2008). Two-way arrows indicate reversibility of the 
reaction. PP1: Protein phosphatase 1. Ca, CaM, Ca2CaM, Ca4CaM, Pi, Pb, Pb2, Pt, Pt2 and Pa, but not PP1, 
can change over time in the model. Values of reaction parameters for this reaction scheme can be found in 
the Appendix.  
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Assumptions/estimated parameter values 
To the best of our knowledge, the concentration of CaMKII in skeletal muscle is unknown. 
We assumed a concentration of 1 µM, which has previously been used for simulations of 
CaMKII in skeletal muscle fibres (Tavi et al., 2003). CaMKII activity in non-stimulated 
muscle is 10% of maximal Ca
2+
/CaM-stimulated activity (Rose et al., 2007a). Therefore, 
the initial concentration of Pa was set to 0.1 µM (see Appendix).  
 Total [CaM] in skeletal muscle has been estimated to be approximately 10-20 µM 
(Chiesi and Carafoli, 1983). However, in many cell types, CaM is presumed to be a 
limiting factor for calcium signalling (Persechini and Stemmer, 2002). In cardiomyocytes, 
most (99%) of CaM is buffered (Wu and Bers, 2007) and assumed to be unavailable for 
binding to CaMKII. Assuming similar CaM buffering in skeletal muscle, we set the 
concentration of free CaM to 0.15 µM (1% of total). [PP1] was set so CaMKII activity 
lasted for several tens of seconds after a simulation of 100 RyR openings, in agreement 
with data from chapter 2. In the model, no diffusion of any of the CaM or CaMKII 
fractions takes place. [CaM] and [CaMKII] were equal in all myoplasmic elements of the 
model, and in the FT and ST models.     
 
Simulations were performed with Matlab (The Mathworks, v7.5.0) on an ASUS K53S 
laptop (2.2GHz processor, 8 GB RAM) and the ordinary differential equation (ODE) 
solver 15s was used. Conservation of mass during the simulations was checked. 
 
 
Results 
 
Model validation 
The calcium dynamics model predicts a substantial spatial gradient in [Ca
2+
] in sarcomeres 
during twitch contraction (Groenendaal et al., 2008). We compared spatially averaged 
[Ca
2+
] during a simulated twitch of the FT and ST versions of the model with experimental 
data obtained from electrically stimulated mouse skeletal muscle fibres (Baylor and 
Hollingworth, 2003). The model describes rise time and peak [Ca
2+
] amplitude of the 
twitch calcium peak quite well (Table 1), but the slow second half of the decrease in [Ca
2+
] 
in ST fibres reported by Baylor and Hollingworth (2003) was absent in the model. 
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Therefore, our modelled ST relaxation time was shorter than the experimentally 
determined relaxation time (Table 1). Adjusting the RyR opening parameters (Appendix) 
did not improve the modelled [Ca
2+
] decrease time without substantial changes in the peak 
[Ca
2+
]. As we judged the peak [Ca
2+
] to be the most important parameter determining 
CaMKII activation, we considered the model to match the experimental data of Baylor & 
Hollingworth sufficiently well to model [Ca
2+
]-dependent CaMKII activation. 
 
 
 Baylor and Hollingworth (2003) Model 
Parameter FT (EDL) ST (SOL) FT  ST 
TTP (ms) 2.0 2.5 2.0 2.1 
Peak [Ca
2+
] (µM) 21.7 8.6 20.2 8.9 
HRT (ms) 2.0 4.4 1.7 1.9 
 
Table 1: Comparison of modelled and experimental [Ca
2+
] during one pulse stimulation 
Experimental measures were carried out on single mouse muscle fibres within small bundles of fibres at 28ºC 
(Baylor and Hollingworth, 2003). Model results were obtained from simulations of a single RyR opening. 
TTP: Time-to-peak [Ca
2+
] during a twitch. HRT: Half-relaxation time of the calcium transient during a 
twitch. FT: fast-twitch. ST: slow-twitch. EDL: mouse m. extensor digitorum longus. SOL: mouse m. soleus.   
 
 
To validate the CaMKII reaction scheme, we first compared modelled Ca
2+
-sensitivity of 
CaMKII autophosphorylation and the effect of phosphatase concentration on this 
relationship to that of an independent experimental dataset (Bradshaw et al., 2003). 
Reagent and ion concentrations, and reaction times described by Bradshaw et al. were used 
for these simulations. The model reproduced the concentration for half-maximal activation 
and steepness of the relationship between [Ca
2+
] and CaMKII autophosphorylation quite 
well (Fig. 2A). Furthermore, we compared the modelled relation between [CaM] and 
CaMKII activity, and between [CaM] and CaMKII autophosphorylation, with another 
independent experimental dataset (Gaertner et al., 2004). The model properly described the 
experimentally determined [Ca
2+
] concentrations for half-maximal CaMKII activity and 
the steepness of the curve (Fig. 2B&C). 
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Figure 2: Validation of CaM-CaMKII reaction scheme 
A: Comparison of modelled [Ca
2+
] - phospho
Thr287
-CaMKII relation (blue lines) with published data (red 
open circles: 0.5 µM PP1; green circles: 2.5 µM PP1) (Bradshaw et al., 2003).  B: Comparison of modelled 
[CaM] - CaMKII activity relation (blue line) with independent experimental data (Gaertner et al., 2004). C: 
Comparison of modelled [CaM] - CaMKII autophosphorylation relation (blue lines) with independent 
experimental data (Gaertner et al., 2004). Experimental data points are estimated from graphs in cited papers. 
PP1: Protein phosphatase 1. 
 
 
Simulation of prolonged repeated opening of the RyR (i.e. >100 openings) resulted in a 
maximum autophosphorylated (Pt, Pt2 & Pa) CaMKII fraction of 14% of total CaMKII. 
This is somewhat lower than the experimentally determined maximal autonomous activity 
of 22-23% of maximal CaMKII activity in in situ stimulated rat m. gatrocnemius muscle 
(Rose et al., 2007a). However, it is in accordance with the experimentally supported idea 
that autonomous CaMKII activity does not exceed a ceiling of approximately 20% of 
maximal activity.  
 
Effect of [Ca
2+
] distribution on CaMKII activation  
We determined maximal total CaMKII activity (defined as the sum of Pb4, Pt2, Pt4 and 
Pa) during simulations of single and repeated RyR openings in the FT and ST model. 
Furthermore, we determined whether there was an effect of RyR opening frequency on 
CaMKII activity, as the frequency of exposure of CaMKII to calcium/calmodulin 
determines the development of CaMKII activity in vitro (De Koninck and Schulman, 
1998). CaMKII activity was determined for each myoplasmic compartment. An overview 
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of the range of increase in CaMKII activity in the myoplasmic elements of the FT and ST 
models can be found in Table 2. 
 
 
   FT  ST 
Twitch Tetanus Train Twitch Tetanus Train 
10 Hz  
0 - 6.5% 
0.2 - 59% 3.6 - 84%  
0 - 1.2% 
0.2 - 29% 3.6 - 44% 
100 Hz 0.5 - 95% 1.9 - 81% 0.7 - 64% 2.3 - 58% 
 
Table 2:  Increase in total CaMKII activity during single or repeated RyR openings 
 
The range of increase in CaMKII activity in myoplasmic elements of FT and ST models 
from the element with the lowest increase to the element with the highest increase. Activity 
was determined at time points during simulations as indicated in Figures 3, 4 & 5.  
  
As expected, the highest CaMKII activity after one simulated RyR opening occurred near 
the calcium release site, and no increase in activity occurred in the elements close to the m-
line (Fig. 3). 
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Figure 3: CaMKII activity during a single RyR opening 
Total simulated CaMKII activity (the sum of Pb4, Pt2, Pt4 and Pa) during a simulated single RyR opening in 
the fast-twitch (FT) and slow-twitch (ST) model (see text for model details). Graphs on the left display 
development of total CaMKII activity over time (in milliseconds) during a single RyR opening in the FT and 
ST model as indicated. Blue lines represent CaMKII activity in different myoplasmic compartments. Black 
inverted triangles indicate the approximate time point at which the CaMKII activity gradient was analysed, 
and visualised in the grids on the right. Note that the scale of the y-axis differs in the FT and ST graph. Grids 
on the right visualise the spatial distribution of the maximal increase in total CaMKII activity during a single 
simulated RyR opening. Colours indicate the percentage increase compared to the initial total activity, and 
the scale is indicated above the figure. Grid layout is the same as in Fig. 1A. The locations of the z-line and 
m-line of the half-sarcomeric model are indicated by Z and M, respectively. NSR: non-junctional 
sarcoplasmic reticulum. JSR: junctional sarcoplasmic reticulum. SERCA: sarco/endoplasmic reticulum Ca
2+
-
ATPase. RyR: Ryanodine receptor.   
 
 
 We investigated whether the CaMKII activity gradient persisted when repeated RyR 
openings were simulated. After ten RyR openings, the spatial gradient in activity increase 
was stronger than after one RyR opening (Table 2, Fig. 4). However, when simulating ten 
repeated trains of ten RyR openings with one-second intervals between the trains, the 
spatial distribution of CaMKII activity during the final ten RyR openings of the protocol is 
remarkably similar to that during the first ten openings. The main difference between the 
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first and last train is an increase in baseline CaMKII activity of the most activated elements 
after the tenth train (Fig. 5), which is mainly due to the increase in fraction Pa, the 
autonomous CaMKII activity. Nevertheless, in all cases CaMKII activation was highest 
near the calcium release site and higher in the elements closest to the z-line than in the 
elements closest to the m-line (Fig. 3). These data suggest that CaMKII activity is highest 
in the vicinity of the calcium release site during muscle contractions.   
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Figure 4: CaMKII activity during repeated RyR openings 
Total simulated CaMKII activity (the sum of Pb4, Pt2, Pt4 and Pa) during a simulation of ten RyR openings 
in the fast-twitch (FT) and slow-twitch (ST) model (see text for model details). Graphs on the left display 
development of total CaMKII activity over time (in milliseconds) during ten simulated RyR openings in FT 
and ST model as indicated, and at a RyR opening frequency of 100Hz (upper two graphs) or 10Hz (lower 
two graphs).  Blue lines represent CaMKII activity in different myoplasmic compartments. In order to 
optimise visualisation of the graphs, the scale of the y-axis differs in each graph. Black inverted triangles 
indicate the approximate time point at which the CaMKII activity gradient was analysed, and visualised in 
the grids on the right. Grids on the right visualise the spatial distribution of maximal total CaMKII activation 
during the simulation of ten RyR openings. Colours indicate the percentage increase compared to the initial 
total activity, and the scale is indicated above the figure. Note that colour scale in this figure is of larger 
magnitude compared to Fig. 3. Grid layout is the same as in Fig. 1A. The locations of the z-line and m-line of 
the half-sarcomeric model are indicated by Z and M, respectively. NSR: non-junctional sarcoplasmic 
reticulum. JSR: junctional sarcoplasmic reticulum. SERCA: sarco/endoplasmic reticulum Ca2+-ATPase. 
RyR: Ryanodine receptor. 
 
 
Models of FT and ST sarcomeres were used to investigate whether CaMKII activation 
differs between these muscle types. CaMKII activation was higher in the FT model 
compared to the ST model after single and repeated RyR openings (Table 2, Fig. 3, 4 & 5). 
This is associated with a higher peak [Ca
2+
] amplitude in the FT model (Table 1), and in 
partial agreement with experimental data demonstrating that phospho
Thr287
-CaMKII levels 
increase in fast-twitch, but not slow-twitch rat muscle after electrical stimulation with 100 
electrical pulses in situ (chapter 2).     
 
To investigate whether RyR opening frequency affects CaMKII activation, we simulated 
repeated RyR openings at both 10 Hz and 100 Hz. After ten RyR openings, CaMKII 
activation was substantially higher when RyR opening occurred at 100 Hz compared to 10 
Hz (Table 2, Fig. 4). However, after ten trains of RyR openings, this difference between 
the frequencies had disappeared in the FT model and was reduced in the ST model (Table 
2, Fig. 5). This was in agreement with experimental data demonstrating no effect of 
frequency on phospho
Thr287
-CaMKII levels after in situ stimulation of rat skeletal muscle 
with 100 electrical pulses at 10 or 150 Hz (Chapter 2). These data suggest that a low 
frequency of RyR opening results in lower CaMKII activation during the initial openings, 
but that as RyR opening continues, the CaMKII activation during low frequency RyR 
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opening eventually matches that during high-frequency RyR opening, and is not likely to 
be a factor during repeated muscle contractions.  
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Fig. 5: CaMKII activity during repeated trains of RyR openings 
Total CaMKII activity (the sum of Pb4, Pt2, Pt4 and Pa) during a simulation of 10 x 10 RyR openings in the 
fast-twitch (FT) and slow-twitch (ST) model (see text for model details). Graphs on the left display 
development of total CaMKII activity over time (in milliseconds) during the 10 x 10 RyR openings protocol 
in FT and ST model as indicated, and at a RyR opening frequency of 100Hz (upper two graphs) or 10Hz 
(lower two graphs). The interval between each train of ten RyR openings was one second. Blue lines 
represent CaMKII activity in different myoplasmic compartments. In order to optimise visualisation of the 
graphs, the scale of the y-axis differs in each graph. Black inverted triangles indicate the approximate time 
point at which the CaMKII activity gradient was analysed, and visualised in the grids on the right. The 
decreasing baseline CaMKII activity can be attributed to PP1 activity, but is adjusted for when calculating 
the increase in activity in each myoplasmic element. Grids on the right visualise the spatial distribution of 
maximal total CaMKII activation during the final 10 pulses of the simulation protocol. Colours indicate the 
percentage increase compared to the initial total activity, and the scale is indicated above the figure. Note that 
the colour scale in this figure is the same as that in Fig. 4, but of a larger magnitude compared to Fig. 3. Grid 
layout is the same as in Fig. 1A. The locations of the z-line and m-line of the half-sarcomeric model are 
indicated by Z and M, respectively. NSR: non-junctional sarcoplasmic reticulum. JSR: junctional 
sarcoplasmic reticulum. SERCA: sarco/endoplasmic reticulum Ca
2+
-ATPase. RyR: Ryanodine receptor.   
 
 
Effect of CaMKII concentration on calcium dynamics in FT and ST fibres 
We used the model to investigate the effect of increased CaMKII concentration, which has 
been shown to increase relaxation speed in rat skeletal muscle (chapter 3), on calcium 
dynamics. CaMKII concentration was increased 50-fold in each myoplasmic element. This 
increased the local concentrations of total active CaMKII during a simulation of a single 
RyR opening compared to the same simulation with 'normal' CaMKII concentration (Fig. 
6A/C). This increase occurred mainly in the elements closest to the RyR. However, it had 
no effect on the development of the [Ca
2+
] or calcium-bound troponin-C concentration 
([Ca
2+
-TropC]) over time in the FT and ST model (Fig. 6B/D).  
 
 
87 
 
 
 
Figure 6: The effect of increased CaMKII levels on twitch characteristics 
A/C: Total CaMKII activity (the sum of Pb, Pt, Pt2 and Pa) during a simulation of a single RyR opening in 
the fast-twitch (FT; A) and slow-twitch (ST; C) model in which CaMKII concentration is increased. Lines 
indicate CaMKII activity in different myoplasmic compartments. Blue lines: [CaMKII] = 1 µM; Red lines: 
[CaMKII] = 50 µM. Note that the scales on the y-axes are different. B/D: Spatially averaged [Ca
2+
] (left 
graphs) and [Ca
2+
-TropC] (right graphs) during a simulation of one RyR opening in the FT (B) and ST (D) 
model. Blue lines: [CaMKII] = 1 µM; Red lines: [CaMKII] = 50 µM. Note that scales on the y-axes are 
different. 
 
 
 An alternative explanation for the experimentally observed increase in relaxation 
speed is an increase in SERCA expression (chapter 3). When increasing maximal SERCA 
activity in the model by two-fold to reflect increased SERCA protein level, [Ca
2+
] and 
[Ca
2+
-TropC] were reduced during the relaxation phase of the twitch (Fig. 7 B/D). These 
data suggest that the decrease in relaxation time when CaMKII is overexpressed in rat 
skeletal muscle cannot be explained by CaMKII-induced increases in SERCA activity, but 
can be at least partially explained by increased SERCA expression levels.  
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Figure 7: The effect of increasing SERCA levels on twitch characteristics 
Spatially averaged [Ca
2+
] (left graphs) and [Ca
2+
-TropC] (right graphs) during a simulation of a single RyR 
opening in the fast-twich (FT) and slow-twitch (ST) model. Blue lines: SERCA activity = normal; Red lines: 
SERCA activity = 2 x normal. Note that scales on the y-axes are different. 
 
 
Discussion  
 
Main findings 
We aimed to investigate whether CaMKII might be differentially activated within a 
sarcomere depending on its subsarcolemmal location and whether decreases in twitch 
contraction and relaxation times after CaMKII overexpression can be explained by 
CaMKII-dependent modification of RyR and SERCA. We found that the modelled spatial 
gradient in cytoplasmic [Ca
2+
] results in a two-fold decrease in CaMKII activity between 
the Ca
2+
 release site (i.e. near the z-line) and the part of the sarcomere close to the m-line. 
This gradient existed during simulations of a single RyR opening and simulations of 
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repeated trains of RyR opening (Fig. 3, 4 & 5). Furthermore, simulated CaMKII activity 
increased more in the FT model than in the ST model (Fig. 3, 4 & 5). Finally, we found 
that CaMKII-dependent modulation of RyR and SERCA cannot explain CaMKII 
overexpression-induced decreases in twitch contraction and relaxation times (Fig. 6). 
 
Model limitations 
RyR and SERCA are both influenced by a plethora of interacting factors (Zalk et al., 2007, 
Vangheluwe et al., 2005), which were not modelled because of the lack of quantitative 
descriptions of their effects. It is unknown whether these factors might mediate or 
influence CaMKII-dependent effects on RyR or SERCA. 
 Direct modification of RyR by a calcium/calmodulin-dependent protein kinase-
dependent phosphorylation has been shown to inhibit RyR opening in isolated SR 
membrane patches of frog skeletal muscle (Wang and Best, 1992). In contrast, 
pharmacological inhibition of CaMKII in single mouse skeletal muscle fibres resulted in 
decreased calcium release during tetanic stimulation (Tavi et al., 2003), which suggests the 
effect of CaMKII on calcium release is stimulatory. We valued the latter study more, as the 
data were obtained from intact fibres with intact SR which may include CaMKII-RyR 
interactions which are no longer present in isolated membrane patches. Therefore, we 
modelled a stimulatory effect of CaMKII on RyR. 
 To the best of our knowledge, the exact concentrations of CaM, CaMKII and PP1 
in skeletal muscle fibres are unknown. PP1 concentration was set based on experimental 
results demonstrating that CaMKII phosphorylation can persist for up to two minutes after 
stimulation of rat skeletal muscle with 100 pulses (chapter 2). The effects of CaM 
concentration on global CaMKII activity in the model indicated that this is an important 
determinant of CaMKII activity (Fig. 8). Although increasing the concentration of CaMKII 
and CaM in the model increased the absolute levels of active CaMKII, a spatial gradient in 
CaMKII activity still existed (see Fig. 6A/C for the effect of increased CaMKII 
concentration).  In addition, increasing the CaM concentration two-fold in the model did 
not affect the conclusion that CaMKII-dependent modification of RyR and SERCA was 
not sufficient to affect the speed of calcium release and re-uptake (Fig. 8).   
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Figure 8: Effect of increased calmodulin concentration on CaMKII activity and calcium release 
Spatially averaged [active CaMKII] during a simulation of 10 repeated pulses at 100 Hz, and  spatially 
averaged [Ca
2+
] and [Ca
2+
-TropC] during a simulation of a single RyR opening in the fast-twich (FT) and 
slow-twitch (ST) models. Blue lines: [CaM] = 0.15µM. Red lines: [CaM] = 0.30 µM. Note that scales on the 
y-axes are different between graphs for FT and ST models. 
 
 
 The experimentally determined effect of CaMKII overexpression on muscle twitch 
relaxation was derived from muscle force traces (chapter 3). Although our model predicted 
that a CaMKII-dependent increase in SERCA expression (chapter 3) leads to a decrease in 
calcium twitch time, the development of force by cross-bridges was not modelled. 
Therefore, it is unclear to what extend the modelled change in calcium dynamics in the 
model translate into a change in force dynamics. However, as differences in calcium 
dynamics are presumed to underlie the difference in twitch time between FT and ST 
muscle (Schiaffino, 2010), the modelled decrease in calcium twitch time is likely to have 
an effect on muscle force dynamics.  
 
Implications of modelling results for the function of CaMKII in skeletal muscle  
CaMKII has many substrates and one mechanism to achieve signalling specificity is 
physical targeting of the kinase to its substrates (Bayer and Schulman, 2001). As our model 
predicted that the spatial gradients in CaMKII activity persist during repeated RyR 
openings, CaMKII substrates in skeletal muscle fibres will be differentially regulated by 
CaMKII, dependent on their subsarcolemmal location (Table 2; Fig. 3, 4, & 5). 
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 RyR is located at the terminal cisternae of the SR (Inui et al., 1987), whereas 
SERCA is located on the longitudinal SR (Jorgensen et al., 1982). CaMKII is targeted to 
the SR by a non-kinase splice variant of the α-CaMKII isoform, αKAP (Bayer et al., 1998). 
αKAP co-localises with SERCA2 to the longitudinal SR in mouse m. soleus fibres (Nori et 
al., 2003), suggesting that CaMKII may be physically targeted to SERCA. Furthermore, 
CaMKII is located at the terminal SR in the vicinity of the RyR (Chu et al., 1990). Thus, 
CaMKII appears to be spatially targeted to these targets. As CaMKII activity is highest at 
the site of RyR, and barely activated at a fraction of the elements that contain SERCA, 
CaMKII-dependent regulation of RyR in muscle fibres may be stronger compared to that 
of SERCA, or the SERCA-associated regulatory proteins phospholamban and sarcolipin.     
 Similarly, local CaMKII activation could have implications for CaMKII-dependent 
regulation of other substrates. CaMKII was found to both complex with, and 
phosphorylate, glyceraldehyde 3-phosphate dehydrogenase, glycogen phosphorylase, 
glycogen debranching enzyme and creatine kinase in SR-membranes, (Singh et al., 2004). 
It is unclear whether this complex is located in the immediate vicinity of RyR, where it 
would be most strongly activated.  
Interestingly, β-CaMKII, including the muscle specific βm isoform, binds to f-actin 
in biochemical essays as well as in cultured neuronal cells, an interaction which has been 
shown to be inhibited by Ca
2+
/CaM-binding (Shen et al., 1998, O'Leary et al., 2006, 
Sanabria et al., 2009). As our simulations suggest that the actin filaments of sarcomeres are 
located in the region where Ca
2+
/CaM-binding to CaMKII takes place (Fig.s 3, 4 & 5), this 
raises the question whether CaMKII might regulate actin assembly or bundling in skeletal 
muscle. However, CaMKII binding to actin in skeletal muscle has not yet been 
demonstrated, and this could be an interesting area for future research.   
 
Overexpression of CaMKII in rat skeletal muscle increases the speed of twitch contraction 
and relaxation (chapter 3). When we increased the CaMKII concentration in the model, the 
calcium and calcium-bound troponin-C concentration dynamics during a single RyR 
opening did not differ from that predicted by the simulation with 'normal' CaMKII 
concentration (Fig. 6). The results of our simulation suggest that CaMKII is barely 
activated during one pulse (Fig. 3), which explains the absence of differences between the 
simulations with different CaMKII concentrations. CaMKII overexpression increased 
SERCA2 expression in rat skeletal muscle (chapter 3). In contrast to only increasing 
92 
 
[CaMKII], additionally increasing maximal SERCA activity in the model caused an earlier 
decrease in [Ca
2+
] and [Ca
2+
-TropC] (Fig. 7B/D). Therefore, increased SERCA expression 
may partially explain the increased relaxation speed observed in CaMKII-overexpressing 
rat muscles (chapter 3).     
 
Although CaMKII activation was highest near the RyR, increasing [CaMKII] in the model 
did not result in a faster rise in [Ca
2+
] in the model (Fig. 6B/D). This is unlikely to be 
related to insufficient CaMKII activity, as increasing baseline CaMKII activity  by 50-fold 
in the model only resulted in an approximate doubling of the peak [Ca
2+
] amplitude, but 
not a decrease in time to peak [Ca
2+
] or [Ca
2+
-TropC] (Fig. 9). More likely, the absence of 
an effect of increased [CaMKII] on [Ca
2+
] rise time is related to the fact that the 
description of RyR in the model and its modification by CaMKII (Appendix) lacks the 
relevant components required to model the physiological effect of CaMKII on the RyR.   
 
 
 
 
Figure 9: Effect of increased basal CaMKII activity on sarcomeric calcium release 
Spatially averaged [Ca
2+
] (left graphs) and [Ca
2+
-TropC] (right graphs) during a simulation of a single RyR 
opening in the fast-twich (FT) and slow-twitch (ST) model. Blue lines:  basal [active CaMKII] = 0.1µM. Red 
lines: basal [active CaMKII] = 5.0µM. Note that scales on the y-axes are different. 
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Finally, we argue that the existence of a spatial gradient in CaMKII activity also has 
implications for the use of constitutively active mutants when using 
transgenic/overexpression approaches to investigate the function of CaMKII, as these 
introduce CaMKII activity distributed throughout the entire cell, and may therefore also 
introduce phosphotransfer activity to substrates that would normally not receive this.  
 
Conclusion  
The model is a useful tool to investigate CaMKII signalling towards its targets in skeletal 
muscle sarcomeres when reaction kinetic information regarding their activation becomes 
available. Our modelling of CaMKII activity in skeletal muscle sarcomeres and its effects 
show CaMKII is locally activated, and its spatial activity gradient is maintained during 
repeated stimulation. Therefore, the location of CaMKII in a sarcomere is likely to be of 
importance for its function and should be considered when evaluating potential CaMKII 
targets for physiological relevance.   
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Appendix: Reaction parameter values 
 
Reaction rate calculations 
Reaction rates for the CaM and CaMKII reaction schemes were calculated as in Saucerman 
&Bers (2008), with the modification of using absolute concentrations of Pi, Pb, Pb2, Pt, 
Pt2 and Pa. Some reactions were excluded as described in the methods section. Values of 
the reaction parameters can be found in the tables below. 
 
Calcium-calmodulin binding 
 
 
Table 2: Reaction parameters for calcium-calmodulin binding  
 
 
CaMKII reactions 
 
Parameter Description Value  Reference 
CaMFreeR Free CaM concentration 0.15 µM (Chiesi and Carafoli, 1983) 
Mg Myoplasmic Mg2+ concentration 1 µM (Jones et al., 2004) 
K Myoplasmic K+ concentration 160 µM (Sejersted and Sjogaard, 2000) 
Kd02 - 14.546 (Saucerman and Bers, 2008) 
Kd24 - 836.69 (Saucerman and Bers, 2008) 
k20 2 Ca dissociation from CaM (C-
terminal) 
10 s
-1 
(Saucerman and Bers, 2008) 
k02 2 Ca binding to CaM (C-terminal) k20/Kd02  µM
-2
 s
-1 
(Saucerman and Bers, 2008) 
k42 2 Ca dissociation from CaM (N-
terminal) 
500  s
-1
 (Saucerman and Bers, 2008) 
k24 2 Ca binding to CaM (N-terminal) k42/Kd24  µM
-2
 s
-1
 (Saucerman and Bers, 2008) 
Parameter Description Value (units) Reference 
CaMKIItot Total CaMKII concentration 1  µM or 50  µM - 
PiR Initial inactive CaMKII fraction 0.9 - 
PbR Initial Ca4CaM-bound CaMKII 0 - 
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Table 3: Reaction parameters for the CaMKII reaction scheme  
 
 
CaMKII-dependent modification of RyR and SERCA 
FT model 
RyR = ([Ca]JSR - [Ca]MYO) * CaMax * (1-e
(-t/tau1)
)
(Power1-DPowermax)
 * (e
(-t/tau2)
)
Power2 
SERCA = CaPump * [Ca]
2 
/ ([Ca]
2 
/ KdPump
2
) 
 
ST model 
RyR: as in FT model 
CaMKIIreg = CaMKactive
3
 / (KmCaMK
3
 + CaMKactive
3
) 
fraction 
Pb2R Initial Ca2CaM-bound CaMKII 
fraction 
0 - 
PtR Initial Ca4CaM-bound pThr287-
CaMKII fraction 
0 - 
Pt2R Initial Ca2CaM-bound pThr287-
CaMKII fraction 
0 - 
PaR Initial unbound pThr287-CaMKII 
fraction 
0.1 (Rose et al., 2007a) 
PP1tot Total PP1 concentration 0.1  µM - 
Kbi Ca4CaM dissociation from Pb 0.54 s
-1
 (Gaertner et al., 2004) 
Kib Ca4CaM binding to Pb  kbi/25.7e-3 µM
-1
s
-1
 (Gaertner et al., 2004) 
kb2i Ca2CaM dissociation from Pb2 14*kbi s
-1
 (Shifman et al., 2006) 
kib2 Ca2CaM binding to Pb2 Kbi µM
-1
s
-1
 - 
kb42 2 Ca dissociation from Pb k42/5 s
-1
   (Shifman et al., 2006) 
kb24  2 Ca binding to Pb2 k24 µM
-2
s
-1
 - 
Kta Ca4CaM dissociation from Pt kbi/1000 s
-1
 (Meyer et al., 1992) 
Kat Ca4CaM binding to Pt kib µM
-1
s
-1
 (Meyer et al., 1992) 
kt2a Ca2CaM dissociation from Pt 14*kta s
-1
 (Shifman et al., 2006) 
kat2 Ca2CaM binding to Pt kib µM
-1
s
-1
 - 
kt42 2 Ca dissociation from Pt k42/5 s
-1
 - 
kt24 2 Ca binding to Pt2 k24 µM
-2
s
-1
 - 
kPP1 Thr287 dephosphorylation 1.72 s
-1
 (Saucerman and Bers, 2008) 
KmPP1 Km for Thr287 dephosphorylation  11 µM (Bradshaw et al., 2003) 
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SERCA = (Jmax_up * CaMKIIreg + 1) * CaPump * [Ca]
2 
/ ([Ca]
2 
/ KdPump
2
)  
 
 
Table 4: Parameters related to RyR and SERCA activity and their CaMKII-dependent modification 
 
 
  
Parameter Description Value (units) Reference 
CaMax Maximum RyR activity FT: 6.981*10
5 
ST: 2.9088* 10
5 
- 
- 
Tau1 RyR opening parameter FT: 1.11 
 
ST:1.1 
(Groenendaal et al., 
2008) 
- 
Tau2 RyR opening parameter FT: 1.4074 
 
ST:1.5 
(Groenendaal et al., 
2008) 
- 
Power1 RyR opening parameter FT: 5 
 
ST:5.2 
(Groenendaal et al., 
2008) 
- 
Power2 RyR opening parameter FT: 3 
 
ST:3 
(Groenendaal et al., 
2008) 
- 
CaPump Maximum SERCA activity FT: 170.2749 
 
ST: 56.7583 
(Groenendaal et al., 
2008) 
(Groenendaal et al., 
2008) 
KdPump [Ca
2+
] at which SERCA activity is half-
maximal 
FT: 1 µM 
 
ST: 1 µM 
(Groenendaal et al., 
2008) 
(Groenendaal et al., 
2008) 
CaMKactive Total concentration of active CaMKII Pb+Pt2+Pt+Pa µM  
KmCaMK Concentration of active CaMKII at which 
effect on substrates is 50% of maximum 
effect 
0.2  µM - 
Jmax_up Maximal % increase in KdPump 70% (Hund and Rudy, 2004) 
DPower1max Maximal % increase in Power 1 30% - 
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Chapter 6: Summary and general discussion 
 
In this chapter, the results of the experiments described in this thesis are summarised and 
suggestions for experiments are made to further elucidate the role of Ca
2+
-calmodulin-
dependent protein kinase II (CaMKII) and calcium-dependent signalling in regulating 
skeletal muscle adaptation.  
 
Summary 
Skeletal muscle is able to adapt its phenotype in response to increased usage, and improve 
its strength and fatigue resistance. Calcium-dependent signalling is presumed to increase 
mitochondrial biogenesis, an important adaptation to improve fatigue-resistance. CaMKII 
has been suggested to promote a slow-twitch, high oxidative phenotype in skeletal muscle, 
but its physiological role in muscle adaptation has so far not been investigated in vivo. The 
work described in this thesis aimed to elucidate the role of CaMKII in skeletal muscle in 
vivo. For this purpose, a rat model which allows for imposing defined stimulation protocols 
on skeletal muscle in situ was combined with the manipulation of CaMKII signalling by 
somatic gene transfer and a computational model of CaMKII signalling.      
 
In chapter 2, the question was addressed whether CaMKII activation depends on 
recruitment frequency and whether its activity remains after muscle stimulation ceases. 
Adult rat skeletal muscle was stimulated in situ by different stimulation protocols after 
which protein levels of total CaMKII and phospho
Thr287
-CaMKII were measured for the 
βM, δA & δD/γB isoforms at different time points. This study consisted of two experiments. 
In the first experiment, m. soleus (SOL) and m. gastrocnemius medialis (GM) were 
stimulated with 100 electrical impulses at 10 or 150 Hz at their active slack length (i.e. a 
length at which no active force is produced). This protocol increased phospho
Thr287
-
CaMKII of δA and δD/γB isoforms in red GM, δA isoform in white GM, but none of the 
isoforms in SOL. There was no effect of frequency on the level of phospho
Thr287
-CaMKII. 
A decrease in total βm and δD/γB CaMKII was observed in GMW after 150 Hz stimulation. 
These results suggest that CaMKII is more strongly activated in fast-twitch muscle, and 
that motor neuron firing frequency is not an important factor in determining CaMKII 
activation. 
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In the second experiment, we sampled GM at rest, after determination of optimum 
length and at 2, 10 or 60 minutes after a two-minute isometric contraction protocol at 
optimum length. The following observations were made: 1) After the contractile activity 
required to determine the optimum length of the muscle, phospho
Thr287
-CaMKII for the δA 
isoform was increased in red GM compared to rest. 2) Phospho
Thr287
-CaMKII was higher 
in white GM compared to red GM regardless of stimulation. 3) Total CaMKII decreased 
over time in white GM. These results suggest that after a short contraction protocol, 
phospho
Thr287
-CaMKII is transiently increased in an isoform- and muscle-dependent way. 
The results of the first and second experiment together suggest that CaMKII remains 
activated for 1 to 15 minutes after stimulation.    
 
In chapter 3, the effects of acute CaMKII overexpression in skeletal muscle in vivo were 
investigated. α/β-CaMKII was overexpressed in adult rat m. gastrocnemius (GM) and m. 
soleus (SOL) by electroporation-mediated gene transfer. We hypothesised that CaMKII 
overexpression would increase the expression of mitochondrial genes. However, our 
experiments showed that CaMKII overexpression did not increase protein levels of 
cytochrome c oxidase IV (COXIV) in GM or SOL. The mRNA levels of oxidative 
phosphorylation components COXIV, COXI and transcriptional co-activator peroxisome 
proliferator-activated receptor gamma co-activator 1α were not different in empty- and 
CaMKII-transfected SOL, whereas succinate dehydrogenase subunit b mRNA was 
decreased in CaMKII-transfected SOL. Force parameters of transfected muscles were 
measured in situ with intact innervations and perfusion. Strength and fatigue resistance of 
control- and CaMKII-transfected SOL and GM did not differ. However, we observed that 
CaMKII overexpression caused a decrease in twitch time-to-peak force and half-relaxation 
time. In addition, CaMKII-overexpressing SOL fibres displayed increased 
sarco/endoplasmic reticulum Ca
2+
-ATPase 2 expression compared to non-transfected 
fibres. Our results therefore suggest that increased CaMKII levels alone are not sufficient 
to increase mitochondrial biogenesis, but may be involved in calcium handling and the 
regulation of contractile force characteristics.  
 
In addition to its role in mitochondrial biosynthesis, CaMKII is presumed to be involved in 
the regulation of a signalling pathway that controls skeletal alpha-actin expression. In 
chapter 4, we investigated the effect of CaMKII overexpression on the transcription of 
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skeletal alpha-actin (SKAA). We hypothesised that CaMKII overexpression would 
increase SKAA promoter activity and mRNA levels. The luciferase gene controlled by a 
SKAA promoter fragment was electro-transferred into m. soleus (SOL) and m. 
gastrocnemius (GM) of both legs. CaMKII was overexpressed in SOL and GM of the right 
leg only. In contrast to our hypothesis, luciferase activity measured in protein extracts of 
the CaMKII-transfected muscles SOL and GM was significantly lower compared to that in 
muscles transfected with the reporter only. SKAA mRNA level tended to be lower in SOL 
of the CaMKII transfected leg, but this was not significant. We concluded that CaMKII 
overexpression had a negative effect on SKAA gene transcription, but that the mechanisms 
underlying this effect require further investigation.  
 
The results described in chapter 3 demonstrated that CaMKII overexpression in vivo 
decreased twitch contraction and relaxation time. However, it was unclear if direct 
CaMKII-dependent modification of the calcium release and re-uptake channels could have 
contributed to this effect. In chapter 5, we investigated whether CaMKII is activated more 
strongly when it’s located in the vicinity of the RyR, and if increasing CaMKII 
concentration in sarcomeres is sufficient to explain decreased twitch contraction and 
relaxation times following CaMKII overexpression in rat skeletal muscle. A mathematical 
model of spatiotemporal sarcomeric [Ca
2+
] dynamics coupled to a biochemical model of 
CaMKII activation was used. The model predicted substantial spatial gradients in CaMKII 
activity in sarcomeres of fast- and slow-twitch muscle fibres during single and repeated 
RyR openings. Increasing CaMKII concentration in the model to mimic CaMKII 
overexpression did not produce decreased twitch contraction and relaxation times as 
observed in vivo (chapter 3). It was suggested that this may be due to the fact that CaMKII 
is minimally activated during a twitch. As CaMKII overexpression was shown to increase 
SERCA2 expression in m. soleus muscle fibres (chapter 3), the effects of increased 
SERCA levels were also modelled. This resulted in a decreased relaxation time in the 
model. We concluded that a CaMKII overexpression-induced increase in SERCA 
expression, but not modification of SERCA, can at least partly explain the observed 
decrease in twitch contraction and relaxation times. 
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Considerations regarding overexpression of wild-type CaMKII by 
electro-assisted gene transfer 
A few technical issues related to the approach used to overexpress CaMKII in rat skeletal 
muscle have not been explicitly addressed in the individual chapters, and will be discussed 
here.   
 
The results of the transfection experiments described in this thesis demonstrate that 
CaMKII overexpression has effects on the expression of SERCA2 protein and skeletal 
alpha-actin promoter activity. This raises the question as to what the mechanisms are via 
which these effects were achieved. It is generally presumed that CaMKII affects cellular 
functions through its kinase activity. Because a wild-type CaMKII was overexpressed, the 
activation of the exogenous CaMKII likely depended on muscle recruitment-induced 
increases in calcium/calmodulin concentration. We attempted to determine whether 
exogenous CaMKII was activated after in situ stimulation of muscle, by comparing 
phospho
Thr287
 levels in stimulated and non-stimulated CaMKII-transfected muscles 
(chapter 3). Although increased phospho
Thr287
 levels of the exogenous β-CaMKII isoform 
was observed in some of these experiments, this was not consistent. It is also possible that 
Ca
2+
/CaM-dependent, rather than Ca
2+
/CaM-independent activity (which is reflected by 
phospho
Thr287
-CaMKII) is increased in CaMKII overexpressing muscles. However, as 
Ca
2+
/CaM-dependent activity cannot be measured, it cannot be concluded with certainty 
that any observed effects of CaMKII overexpression are due to increased (contraction-
induced) kinase activity. 
 
COXIV was measured as a marker of mitochondrial density, as its expression in skeletal 
muscle is increased by CaMKIV and PGC-1 overexpression (Wu et al., 2002, Jiang et al., 
2010) , and therefore we hypothesised that COXIV expression would be increased in rat 
skeletal muscle by CaMKII overexpression. An increase in COXIV expression would not 
have demonstrated an increase in functional mitochondria, as these consist of many 
different proteins. However, if mitochondrial volume density had increased, COXIV 
protein levels would have been increased. As we observed no difference in COXIV protein 
level between control- and CaMKII-transfected muscles, we presume that the volume of 
functional mitochondria was also not increased in CaMKII-transfected muscles. 
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 Electroporation was used to induce uptake of plasmid DNA by the muscle fibres. 
This method is thought to result in the permeabilization of the cell membrane, allowing 
DNA molecules to enter the cytoplasm. Thus, the method depends on the induction of 
some degree of damage to the muscle fibres. To identify the effects of CaMKII 
overexpression, CaMKII-transfected fibres were compared to adjacent non-transfected 
fibres. As described in chapter 3, separation of these two fibre populations was based on 
visual inspection of CaMKII immunostaining intensity. Both fibre populations contained 
centrally-nucleated fibres, indicating ongoing regeneration. Therefore, it is conceivable 
that both populations have taken up the plasmid DNA, but that the 'non-transfected' fibres 
expressed the encoded CaMKII at much lower levels. This might be an explanation for the 
absence of a difference in COXIV expression. However, we did detect a significant 
difference in SERCA2 immunostaining intensity between transfected and non-transfected 
muscle fibres. Therefore, it seems likely that the difference in CaMKII expression levels 
achieved between 'CaMKII-transfected’ and 'non-transfected' fibres is of a sufficient 
magnitude to expose CaMKII-dependent effects on protein expression.  
 
Regulation of CaMKII activity in skeletal muscle 
Although CaMKII is known to be activated during exercise in humans (Rose and 
Hargreaves, 2003), very little is known about the physiological regulation of this activity. 
In this section, we discuss the factors that regulate activation and deactivation of CaMKII 
in skeletal muscle. 
 
CaMKII activation 
A large degree of variation in levels of phospho
Thr287
-CaMKII was observed in resting SOL 
and GM compared to the magnitude of the effect of in situ stimulation on the levels of 
phospho
Thr287
-CaMKII in these muscles as reported in chapter 2. The relatively high 
variation in phospho
Thr287
 could be related to the fact that the muscles were not 
immediately sampled after the contraction protocols. However, this suggestion was not 
supported by experiments described in chapter 3, whereby transfected muscles were 
freeze-clamped after two minutes of stimulation. In these experiments, no consistent 
increases in phospho
Thr287
 levels of the endogenous CaMKII isoforms were detected 
(Chapter 3, Fig. 2). Combined with the difference in resting levels of phospho
Thr287
-
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CaMKII, this demonstrates that other factors than neural stimulation regulate CaMKII 
phosphorylation.  
Passive stretch of mouse EDL and SOL ex vivo (i.e. without intact neural stretch 
reflex loops) increased phospho
Thr287
-CaMKII in these muscles (Jensen et al., 2007), and 
may therefore be one such non-neural factor. However, as the muscles in the 'slack 
contraction' experiment (chapter 2) were not stretched and a substantial degree of variance 
in phospho
Thr287
-CaMKII levels was still observed, this is unlikely to be one of the main 
factors causing the variance in phospho
Thr287
-CaMKII levels in the muscles in our 
experiments. A possibility is that the calmodulin concentration differs in muscles from 
different animals. As reported in chapter 5, calmodulin concentration may be a limiting 
factor for CaMKII activation, and therefore a higher calmodulin concentration may lead to 
a higher CaMKII activity upon neural stimulation. Intramuscular calmodulin concentration 
doubled within two days of chronic electrostimulation of rabbit EDL (Antipenko et al., 
1999), suggesting that calmodulin expression is in fact regulated by long-term muscle 
activity pattern. However, this would not explain the variation in the resting level of 
phospho
Thr287
, as the animals used during our experiments were not trained and had similar 
activity patterns as they were kept in cages until the measurements were carried out. 
Therefore, it is still unclear what caused the variation in the phospho
Thr287
-CaMKII levels 
in SOL and GM in our experiments. 
 
The regulation of CaMKII activation may depend on the muscle phenotype. The modelling 
results of chapter 5 suggest that the higher amplitude of fast-twitch (FT) calcium transients 
activate CaMKII to a greater extend in FT muscle compared to slow-twitch (ST) muscle. 
This is supported by the experimental data reported in chapter 2, which demonstrated that 
CaMKII autophosphorylation was increased in fast-twitch GM, but not in slow-twitch SOL 
after in situ stimulation with 100 electrical pulses. To the best of our knowledge, no other 
study has investigated electrical stimulation-induced CaMKII phoshorylation in different 
muscle types. Further work is required to determine whether the difference in stimulation-
induced phospho
Thr287
-CaMKII levels in FT and ST muscles persists during longer 
stimulation protocols reflecting exercise sessions.  
 In addition to affecting stimulation-induced CaMKII phosphorylation, muscle type 
also has an effect on basal levels of phospho
Thr287
-CaMKII. Increased resting levels of 
phospho
Thr287
-CaMKII levels were observed in skeletal muscle after a period of one-legged 
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endurance training in humans (Rose et al., 2007b) and after chronic overloading of chicken 
muscle (Fluck et al., 2000b). As these training sessions increased the expression of genes 
involved in regulating oxidative metabolism and muscle size, respectively, these results 
suggest that the increased basal phospho
Thr287
-CaMKII levels may be involved in 
establishing a new muscle phenotype. However, higher levels of basal phospho
Thr287
-
CaMKII were observed in rat low-oxidative white GM compared to high oxidative red GM 
(chapter 2) and in mouse fast-twitch, low-oxidative EDL muscle compared to slow-twitch 
high-oxidative SOL (Jensen et al., 2007). Therefore, basal phospho
Thr287
-CaMKII levels in 
skeletal muscle is not simply higher as the oxidative capacity of the muscle increases, and 
different mechanisms may regulate resting CaMKII phosphorylation in trained and 
untrained muscle. It is currently unclear what the mechanisms are that lead to these 
increased basal levels of phospho
Thr287
-CaMKII levels.  
  
The development of autonomous CaMKII activity is dependent on the frequency of 
exposure of the enzyme to Ca
2+
/CaM (De Koninck and Schulman, 1998). However, we 
observed no effect of neural activation frequency on phospho
Thr287
-CaMKII in experiments 
where muscles at their active slack length were stimulated in situ (chapter 2). Furthermore, 
our simulations of CaMKII activity development suggested that the RyR opening 
frequency only has an effect on phospho
Thr287
-CaMKII levels during the first few RyR 
openings (chapter 5). Therefore, the biochemical ‘Ca2+/CaM-frequency decoding’ property 
of CaMKII appears to be relevant in whole muscle only during the initial RyR openings. 
This may be explained by the following three mechanisms: 1) the high frequency of 
calcium release in rat skeletal muscle compared to those used during the in vitro 
experiments by De Koninck & Schulman (13-250 Hz (Hennig and Lomo, 1985) versus 1-4 
Hz (De Koninck and Schulman, 1998)), 2) the relatively slow deactivation of 
phosphorylated CaMKII after muscle stimulation (chapter 2) and 3) the existence of a 
maximum level of autophosphorylated CaMKII in skeletal muscle (chapter 5).  
 
One study has claimed that the frequency at which multiple contractions occur determines 
CaMKII activity. This conclusion was based on mathematical modelling and the 
observation that KN93, a pharmacological inhibitor of CaMK’s, inhibited calcium release 
in single fast-twitch mouse muscle fibres when contractions occurred at 100 ms intervals, 
but not when contractions occurred at 5 second intervals (Aydin et al., 2007). However, 
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CaMKII phosphorylation and activity were not measured during this study. Therefore, 
experiments that employ muscle contraction protocols with repeated contractions followed 
by measurement of CaMKII phosphorylation and/or activity are still required to confirm 
whether the frequency of muscle contraction has an effect on CaMKII activation.  
 
It cannot be excluded that calcium influx from other sources than the SR is important for 
CaMKII activation. Extracellular calcium can enter the cytoplasm through store-operated 
calcium entry (via SR protein stromal interaction molecule 1 and the Orai1 calcium 
channel), excitation-coupled calcium entry and transient receptor potential channels 
(TRPC’s) (Dirksen, 2009)). Although calcium influx through TRPC3 has been implicated 
in the activation of the calcineurin - nuclear factor of activated t-cells (NFAT) pathway 
(Rosenberg et al., 2004), very little is known about the magnitude of calcium influx 
through these channels and as of yet no implications for CaMKII activation can be derived. 
The calcium concentration in myonuclei also increases during electrical stimulation 
of muscle fibres, but with slower dynamics compared to those in the cytoplasm (Liu et al., 
2005). CaMKII-like activity has been demonstrated in nuclei isolated from chicken skeletal 
muscle (Fluck et al., 2000a). Some studies have claimed that CaMKII in the nucleus is 
phosphorylated after exercise based on immunohistochemical measures (Smith et al., 2008, 
Liu et al., 2005) but these data are not convincing as comparisons of staining intensities 
between different stained sections were made. Therefore, the results are likely to be 
affected by differences in staining quality and imaging settings between the different 
sections. It is currently unknown which CaMKII isoforms are within the myonucleus, and 
therefore they cannot be distinguished on the western blots performed in chapters 2 and 3.   
The roles of the different CaMKII isoforms and whether they are differentially 
localized in muscle fibres (as for example in cardiac myocytes (Ramirez et al., 1997)) 
requires further investigation. This knowledge will aid in determining which calcium 
micro-domains are important for their activation, and therefore help relate the 
physiological contraction-related stimuli to CaMKII-dependent downstream effects. 
Possibly, this could be done by overexpression of specific CaMKII isoforms, or targeting 
these isoforms for degradation using RNA interference (RNAi). These RNAi constructs 
would likely have to be targeted to the variable region within the association domain in 
order to knock-down individual isoforms (Hudmon and Schulman, 2002). 
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Oxidation of methionine residues 281/282 gives CaMKII autonomous activity in a 
mechanism parallel to autophosphorylation (Erickson et al., 2008). Like 
autophosphorylation of Thr287, oxidation of Met281/282 requires initial binding of 
Ca
2+
/CaM and prevents blocking of the catalytic domain by the autoinhibitory domain 
(Erickson et al., 2008). Prevention of CaMKII oxidation by overexpression of methionine 
sulfoxide reductase A mitigated aldosterone-induced cardiac rupture in mice (He et al., 
2011). This suggests that oxidation-dependent CaMKII activity has effects separate from 
those of autophosphorylation-dependent CaMKII activity in the heart. The role of oxidized 
CaMKII has not been the subject of any investigation in skeletal muscle. The formation of 
oxygen radicals is also induced in contracting skeletal muscle (Powers and Jackson, 2008), 
and it would therefore be of interest to determine whether oxidation of CaMKII occurs in 
skeletal muscle.  
 
CaMKII de-activation 
Much like the factors that regulate the activation of CaMKII, the factors that regulate the 
de-activation of CaMKII have received very little attention. Although Ca
2+
/CaM is 
released from CaMKII when the intracellular [Ca
2+
/CaM] is low, phosphorylation of 
CaMKII can only be reversed by the action of phosphatases. In both the ‘two-minute 
isometric contractions’ and ‘slack contraction’ experiments described in chapter 2, 
increased levels of phospho
Thr287
-CaMKII in rat skeletal muscle were increased after very 
brief stimulation (approximately 100 pulses) and remained up to 15 minutes after 
stimulation of rat skeletal muscle. This suggests that CaMKII autophosphorylation enables 
CaMKII to outlast the Ca
2+
/CaM stimulus in skeletal muscle required for its initial 
activation.   
One study observed increasing CaMKII activity and phospho
Thr287
-CaMKII levels  
in rat fast-twitch EDL muscle in situ during stimulation up to 3 minutes after which both 
activity and phosphorylation decreased during continued stimulation (Rose et al., 2007a). 
In chapter 2, we reported that although phospho
Thr287
-CaMKII levels for the δA-CaMKII 
isoform were increased after the activity required to determine optimum muscle length, 
phospho
Thr287
-CaMKII was not increased for any of the CaMKII isoforms after a further 
two minute isometric contraction protocol (chapter 2). This suggests that muscle 
stimulation increases CaMKII phosphorylation, but also activates a pathway that 
dephosphorylates CaMKII, so that an elevated level of phospho
Thr287
-CaMKII is only 
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maintained after brief stimulation, and CaMKII is dephosphorylated during prolonged 
stimulation. The identity of this pathway for CaMKII dephosphorylation in skeletal muscle 
is currently unknown and requires further investigation.  
 
CaMKII function in skeletal muscle 
The current view in the literature is that CaMKII is involved in the regulation of 
mitochondrial biogenesis in skeletal muscle. However, our data indicate that basal levels of 
phospho
Thr287
-CaMKII are higher in low-oxidative white compared to high-oxidative red 
rat m. gastrocnemius medialis (chapter 2). This result and the observation that CaMKII 
overexpression did not increase COXIV expression (chapter 3) indicate that increased 
CaMKII autophosphorylation and protein level are not sufficient to increase COXIV 
expression, which is essential to increase mitochondrial capacity. A possibility which has 
not yet been discussed is that CaMKII induced paracrine signalling that stimulated COXIV 
expression in non-transfected fibres as well as CaMKII-overexpressing fibres in the same 
muscle. In this case, there would not be a difference in COXIV staining intensity on the 
level of single fibres, but there would be a difference in COXIV expression between 
control- and CaMKII-transfected muscles detected by western blot. However, we observed 
no difference on COXIV levels between control- and CaMKII-transfected muscles on a 
western blot (Fig. 1). 
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Figure 1: The effect of CaMKII overexpression on COXIV protein levels in whole muscle 
Graphs display COXIV protein levels in control- (CON) and CaMKII-transfected GM (A) and SOL (B) as 
determined by western blotting followed by immunodetection. Bars represent mean COXIV and points 
represent the data obtained from individual samples. Points connected by a dashed line represent intra-animal 
muscle pairs. Significance of the difference between control- and CaMKII-transfected muscle s is indicated. 
Example blots are shown below the graphs. Actin was detected by ponceau s staining of the blot and serves 
as a loading control.  
 
CaMKII per se may not be sufficient to induce mitochondrial biogenesis but it might be 
required in combination with other stimuli. This was indirectly suggested by the 
observation that the pharmacological CaMK inhibitor KN93 inhibited calcium-dependent 
activation of p38 mitogen-activated protein kinase (MAPK) in mouse epitrochlearis muscle 
ex vivo (Wright et al., 2007). MAPK inhibition had been demonstrated in the same study to 
inhibit calcium-dependent mitochondrial gene expression. However, this study did not 
measure the effect of CaMKII inhibition on mitochondrial expression directly. Inhibition 
of CaMKII in mouse skeletal muscle in vivo has been carried out, but no data on 
mitochondrial gene expression have been reported (Murgia et al., 2009). It is therefore still 
unclear whether CaMKII is required for mitochondrial gene expression in vivo. 
 
In contrast, the data presented in chapters 3 and 4 suggest that CaMKII overexpression is 
sufficient to increase SERCA2 protein expression and decrease skeletal alpha-actin 
promoter activity. This suggests that CaMKII does influence gene expression in skeletal 
muscle. Can putative CaMKII-dependent pathways of gene regulation explain increased 
SERCA2 expression? The SERCA2a promoter contains a serum response element (SRE) 
(Baker et al., 1998), and SRF overexpression resulted in decreased SERCA2 mRNA levels 
in cardiomyocytes (Zhang et al., 2001). This suggests that SRF might have an inhibitory 
effect on SERCA2 transcription. As CaMKII phosphorylates SRF at sites which either 
inhibit or stimulate its DNA binding (Fluck et al., 2000a, Rivera et al., 1993, Wheaton and 
Riabowol, 2004), our results suggest that CaMKII overexpression inhibited SRF DNA 
binding and decreased the activity of the SRF promoter construct (which contains three 
SREs (chapter 4)). Possibly by the same mechanism, CaMKII overexpression increased 
SERCA2 expression (chapter 3). In addition to SRF, MEF2 might be a CaMKII-regulated 
factor which mediates increases in SERCA expression (Lu et al., 2000a). A MEF2 site is 
present on the SERCA promoter, but SERCA promoter activity in cardiomyocytes is only 
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increased when MEF2 is co-overexpressed with NFAT (Vlasblom et al., 2004), which is 
not known to be regulated by CaMKII. It should be noted that no increase in SERCA 
mRNA was observed in the CaMKII overexpression experiments in chapter 3. In 
conclusion, our data point to SRF as a possible mediator of CaMKII-dependent signalling 
in skeletal muscle in vivo, but its actual involvement still requires experimental 
verification.  
 
Interestingly, δ-CaMKII expression increases in regenerating muscle (Abraham and Shaw, 
2006). Increased calcium influx through damaged muscle membranes is thought to be an 
important factor in the pathophysiology of dystrophic muscle, as it may activate calcium-
dependent proteases such as calpains (Whitehead et al., 2006). Stimulation of calcium 
removal from the cytoplasm by SERCA overexpression mitigates the dystrophic phenotype 
in skeletal muscle of mdx mice (Goonasekera et al., 2011). In the electroporated muscles in 
chapter 3, SERCA2 expression was decreased in the damaged electroporated region 
compared to the non-electroporated region (Fig. 2). SERCA2 expression in m.soleus is also 
decreased during myotoxin-induced regeneration (Zador et al., 1996). In contrast, CaMKII 
overexpression increased SERCA2 protein expression (chapter 3, Fig. 6). Furthermore we 
observed a normalization of twitch contraction and relaxation time (chapter 3, Fig. 5). 
However, no improvements in maximal forceof the CaMKII-overexpressing muscles were 
observed seven days after transfection.  Whether CaMKII overexpression decreases resting 
calcium level or calcium transients during muscle stimulation will require experimental 
verification. CaMKII could be co-overexpressed with a calcium-sensitive probe which 
allows for in vivo imaging (Rudolf et al., 2004). A comparison can then be made with the 
contra-lateral muscle overexpressing the probe only. To conclude, our results suggest that 
CaMKII may stimulate muscle regeneration by increasing SERCA2 expression. 
 
 
Figure 2: Decreased SERCA2 protein in damaged SOL fibres 
Immunofluorescence image of SOL subjected to electroporation 
procedure and stained for SERCA2. The left half of the image 
contains small regenerating fibres, whereas the right half of the 
fibres is undamaged.The lower staining intensity in the 
regenerating fibres indicates lower SERCA2 levels in these fibres.   
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The combined results of the stimulation and transfection studies in this thesis suggest that 
CaMKII regulates gene expression in skeletal muscle, but that its muscle recruitment-
dependent activity is limited to brief periods during and after muscle recruitment. The 
CaMKII activity pattern suggests that it is mostly involved in regulating acute processes 
during muscle contraction, rather than regulating processes such as the changes in gene 
expression during the recovery period after exercise. How can this apparent contradiction 
be explained? Firstly, it is not quite clear what the role of basal CaMKII activity in muscle 
is. As shown in chapter 2, there are differences in basal CaMKII phosphorylation between 
different muscle fibre types, and some studies have demonstrated an increase in basal 
CaMKII phosphorylation after a period of training (Rose et al., 2007b, Fluck et al., 2000b). 
It may be that changes in basal activity and expression are related to adaptation (though not 
of oxidative capacity), and that contraction-induced activity is related to acute functions 
such as glycogen metabolism and calcium release. The latter hypothesis is supported by the 
modelling results described in chapter 5, which show that the increase in CaMKII activity 
is largest near substrates involved in regulating glycogen metabolism and calcium release 
(Singh et al., 2004, Leddy et al., 1993). Assessment of the impact of changes in basal 
CaMKII activity on muscle phenotype requires experiments in which skeletal muscles in 
vivo are overexpressing a constitutively active CaMKII-mutant. As of yet such experiments 
have not been carried out, but using the methods described in this thesis will provide 
relevant information regarding the role of CaMKII in skeletal muscle adaptation.  
 
The role of calcium in mitochondrial gene expression 
Calcium influx into skeletal muscle is generally considered to be a factor which stimulates 
mitochondrial biogenesis (Ojuka et al., 2003, Wright et al., 2007, Bruton et al., 2010). This 
raises the question as to what the mechanism is through which the calcium-dependent 
increases in mitochondrial biogenesis are achieved. Constitutively active calcineurin 
increases mitochondrial biogenesis in mouse skeletal muscle (Long et al., 2007, Jiang et 
al., 2010), and thus the effects of increasing calcium concentration may be mediated by 
calcineurin. However, an alternative explanation is that the effects of chronically elevated 
calcium concentration may be caused by indirect effects (i.e. not requiring calcium-
dependent molecules). Increased cellular energy expenditure is likely required because 
calcium needs to be actively removed from the cytoplasm as continuously elevated calcium 
concentrations are associated with skeletal muscle pathology (Oberc and Engel, 1977). The 
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resulting increase in intracellular AMP, and decrease in ATP concentration could activate 
AMPK, which appears to be sufficient to increase mitochondrial gene expression (Garcia-
Roves et al., 2008). Alternatively, the increased calcium levels may have activated CaMK 
kinase (CaMKK), which activate AMPK in skeletal muscle (Jensen et al., 2007). CaMKK 
can be inhibited by KN93 (Jensen et al., 2007), and this might therefore explain the 
observed KN93-dependent attenuation of mitochondrial gene expression in response to 
calcium (Wright et al., 2007).  
 
A promising approach to test the physiological role of calcium in muscle adaptation 
without chronically elevating the intracellular calcium concentration is to use actomyosin-
ATPase inhibitors to separate the calcium influx from muscle contraction (Dentel et al., 
2005). This experiment cannot be carried out in situ or in vivo, as the actomyosin inhibitor 
would paralyse the diaphragm. Isolated muscles should be incubated with or without the 
inhibitor, and stimulated with a protocol that stimulates mitochondrial gene expression. A 
comparison with unstimulated muscles should identify whether physiologically relevant 
calcium transients can stimulate mitochondrial gene expression to the same extend as 
observed in contracting skeletal muscle. 
 
Conclusion 
The aim of this thesis was to elucidate the role of CaMKII in skeletal muscle adaptation in 
vivo. We conclude that CaMKII is activated by very brief stimulation in a recruitment 
frequency-independent manner, and that increased CaMKII protein levels increase 
SERCA2 expression, but not mitochondrial gene expression. We speculate that 
contraction-induced CaMKII activity may be mainly involved in regulating acute processes 
in skeletal muscle, and that chronic increases in CaMKII activity regulate long-term 
adaptation of skeletal muscle. The adaptations regulated by CaMKII are still unclear and 
deserve further investigation.   
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